<SEC-DOCUMENT>0001171843-20-006556.txt : 20200922
<SEC-HEADER>0001171843-20-006556.hdr.sgml : 20200922
<ACCEPTANCE-DATETIME>20200922071426
ACCESSION NUMBER:		0001171843-20-006556
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20201026
FILED AS OF DATE:		20200922
DATE AS OF CHANGE:		20200922

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RedHill Biopharma Ltd.
		CENTRAL INDEX KEY:			0001553846
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35773
		FILM NUMBER:		201187858

	BUSINESS ADDRESS:	
		STREET 1:		21 HA'ARBA'A STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64739
		BUSINESS PHONE:		972-3-541-3131

	MAIL ADDRESS:	
		STREET 1:		21 HA'ARBA'A STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64739
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k_092220.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>UNITED STATES</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Washington, D.C.&nbsp;20549</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>FORM 6-K</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Report of Foreign Private Issuer</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Pursuant to Rule 13a-16 or 15d-16</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>of&nbsp;the Securities Exchange Act of 1934</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">For the month of September 2020<br>
Commission File No.:001-35773</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 18pt; text-align: center; margin: 0pt 0"><b>REDHILL BIOPHARMA LTD.</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">(Translation of registrant&rsquo;s name into English)</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>21 Ha'arba'a Street, Tel Aviv, 6473921, Israel</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">(Address of principal executive offices)</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 28.35pt; margin: 0pt 0">Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 28.35pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 14.2pt; margin: 0pt 0">Form 20-F&nbsp;&#9746;&nbsp;Form 40-F&nbsp;&#9744;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 14.2pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 28.35pt; margin: 0pt 0">Indicate by check mark if the Registrant is&nbsp;submitting&nbsp;the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 28.35pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 28.35pt; margin: 0pt 0">Indicate by check mark if the Registrant is&nbsp;submitting&nbsp;the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 28.35pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">Attached hereto and incorporated herein by reference is the notice
and proxy statement for the extraordinary general meeting of shareholders of the Company scheduled for October 26, 2020.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">This Form 6-K is incorporated by reference into the Company's Registration
Statements on Form S-8 filed with the Securities and Exchange Commission on May 2, 2013 (Registration No. 333-188286), on October
29, 2015 (Registration No. 333-207654), on July 25, 2017 (Registration No. 333-219441), on May 23, 2018 (Registration No. 333-225122)
and on July 24, 2019 (File No. 333-232776) and its Registration Statements on Form F-3 filed with the Securities and Exchange Commission
on February 25, 2016 (Registration No. 333-209702), on July 23, 2018 (File No. 333-226278) and on July 24, 2019 (File No. 333-232777).</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>SIGNATURES</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">Pursuant to the requirements of&nbsp;the&nbsp;Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td colspan="2">REDHILL BIOPHARMA LTD.</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td colspan="2">(the &quot;Registrant&quot;)</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="width: 57%">&nbsp;</td>
    <td style="width: 4%">&nbsp;</td>
    <td style="width: 30%">&nbsp;</td>
    <td style="width: 9%">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>Date: September 22, 2020</td>
    <td>By:</td>
    <td style="border-bottom: Black 1pt solid">/s/ Dror Ben-Asher</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td colspan="2">Dror Ben-Asher</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td colspan="2">Chief Executive Officer </td>
    <td>&nbsp;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>REDHILL BIOPHARMA LTD.<br>
21 Ha'arba'a Street</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Tel-Aviv 6473921 </b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Israel</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>To Be Held on October 26, 2020 </b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Extraordinary General Meeting of Shareholders
of RedHill Biopharma Ltd. (the &ldquo;Company&rdquo;), will be held at the offices of the Company, 21 Ha'arba'a Street, 16<sup>th</sup>
Floor, Tel-Aviv, Israel, on October 26, 2020, at 3:00 p.m. Israel time, or at any adjournments thereof (the &ldquo;General Meeting&rdquo;),
for the following purposes:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">1.</td><td style="text-align: justify">To approve an amendment to the Company's Compensation Policy regarding the D&amp;O insurance premium;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">2.</td><td style="text-align: justify">To approve an amendment to the Amended and Restated Articles of Association of the Company to add
a forum selection provision;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">3.</td><td style="text-align: justify">To approve amendments to the employment terms of Mr. Dror Ben-Asher, the Company&rsquo;s Chief
Executive Officer;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">4.</td><td style="text-align: justify">To approve an amendment to the employment terms of Mr. Rick Scruggs, the Company&rsquo;s Chief
Commercial Officer;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">5.</td><td style="text-align: justify">To approve the repricing of options exercisable into American Depository Shares (&ldquo;ADSs&rdquo;)
of the Company granted to Mr. Rick Scruggs;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">6.</td><td style="text-align: justify">To approve the extension of options to purchase ADSs of the Company previously granted to members
of the board of directors; and</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">7.</td><td style="text-align: justify">To approve the extension of options to purchase ADSs of the Company previously granted to Mr. Dror
Ben-Asher.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">The Company is currently unaware of any other
matters that may be raised at the General Meeting. Should any other matters be properly raised at the General Meeting, the persons
designated as proxies shall vote according to their own judgment on those matters.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Only holders of record of ordinary shares, par
value NIS 0.01 per share (the &ldquo;Ordinary Shares&rdquo;), and holders of record of ADSs, evidenced by American Depositary Receipts
issued by The Bank of New York Mellon at the close of business on September 22, 2020 shall be entitled to receive notice of and
to vote at the General Meeting.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board of Directors recommends that you vote
FOR the proposals, as specified on the enclosed form of proxy.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">Whether or not you plan to attend the General
Meeting, it is important that your ADSs or ordinary shares be represented. Accordingly, you are kindly requested to complete, date,
sign and mail the enclosed proxy in the envelope provided at your earliest convenience so that it will be received no later than
four hours prior to the General Meeting. Execution of a proxy will not in any way affect a shareholder&rsquo;s right to attend
the General Meeting and vote in person, and any person giving a proxy has the right to revoke it at any time before it is exercised.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt"></p>

<p style="margin: 0pt 1.45pt 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">Shareholders
who hold Ordinary Shares through members of the Tel-Aviv Stock Exchange and intend to vote their Ordinary Shares either in person
or by proxy must deliver to the Company, no later than October 26, 2020, at 11:00 a.m. Israel time, an ownership certificate confirming
their ownership of the Ordinary Shares on September 22, 2020 (the &ldquo;Record Date&rdquo;), which certificate must be approved
by a recognized financial institution, as required by the Israeli Companies Regulations (Proof of Ownership of Shares for Voting
at General Meeting) of 2000, as amended.</p>

<p style="margin: 0pt 1.45pt 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="margin: 0pt 1.45pt 0pt 2.1pt; font-size: 10pt; text-align: justify; text-indent: 33.35pt; background-color: white">ADS
holders should return their proxies by the date set forth on their form of proxy.</p>

<p style="margin: 0pt 1.45pt 0pt 2.1pt; font-size: 10pt; text-align: justify; text-indent: -0.65pt; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">Shareholders wishing to express their position
on an agenda item for this General Meeting may do so by submitting a written statement (&ldquo;Position Statement&rdquo;) to the
Company&rsquo;s offices, c/o Mr. Micha Ben Chorin, at 21 Ha'arba'a Street, Tel-Aviv, 6473921 Israel, by no later than October 18,
2020. Any Position Statement received, that is in accordance with the guidelines set by the Companies Law, will be furnished to
the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on Form 6-K, and will be made available to the public
on the Commission&rsquo;s website at&nbsp;<u>http://www.sec.gov</u>.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">If within half an hour from the time
appointed for the General Meeting a quorum is not present, the General Meeting shall be adjourned to the next business day following
the day of the scheduled General Meeting, at the same time and place, or at another day, time and place prescribed by the Board
of Directors in a notification to the shareholders.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">This Notice and the documents mentioned therein,
as well as the proposed resolutions on the agenda, can be viewed at the Company's registered office on 21 Ha'arba'a Street, Tel-Aviv,
Tel: +972 3 541 3131, Sunday through Thursday between 10:00-15:00, and also will be made available to the public on the Commission&rsquo;s
website at&nbsp;<u>http://www.sec.gov</u>.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 56%">&nbsp;</td>
    <td style="width: 44%">By Order of the Board of Directors,</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td>Dror Ben-Asher</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td>Chairman of the Board of Directors </td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>Tel-Aviv, Israel</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>September 22, 2020</td>
    <td>&nbsp;</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>REDHILL BIOPHARMA LTD. </b><br>
<br>
</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>21 Ha'arba'a Street </b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Tel-Aviv 6473921 </b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Israel</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>PROXY STATEMENT</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><br>
FOR EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS </b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>To Be Held on October 26, 2020</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This Proxy Statement is furnished to the
holders of ordinary shares, par value NIS 0.01 per share (the &ldquo;Ordinary Shares&rdquo;), and to holders of American
Depository Shares (&ldquo;ADSs&rdquo;), evidenced by American Depositary Receipts issued by The Bank of New York Mellon
(&ldquo;BNY Mellon&rdquo;), of RedHill Biopharma Ltd. (the &ldquo;Company&rdquo; or &ldquo;RedHill&rdquo;) in connection with
the solicitation by the board of directors of the Company (the &ldquo;Board of Directors&rdquo; or the &ldquo;Board&rdquo;)
of proxies for use at the Extraordinary General Meeting of Shareholders (the &ldquo;General Meeting&rdquo;), to be held on
Monday, October 26, 2020, at 3:00 p.m. Israel time at the offices of the Company, 21 Ha'arba'a Street, 16<sup>th</sup> Floor,
Tel-Aviv, Israel, or at any adjournments thereof.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">It is proposed at the General Meeting to adopt the following proposals or
to consider the following items:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">1.</td><td style="text-align: justify">To approve an amendment to the Company's Compensation Policy regarding the D&amp;O insurance premium;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">2.</td><td style="text-align: justify">To approve an amendment to the Amended and Restated Articles of Association of the Company to add
a forum selection provision;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">3.</td><td style="text-align: justify">To approve amendments to the employment terms of Mr. Dror Ben-Asher, the Company&rsquo;s Chief
Executive Officer;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">4.</td><td style="text-align: justify">To approve an amendment to the employment terms of Mr. Rick Scruggs, the Company&rsquo;s Chief
Commercial Officer;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">5.</td><td style="text-align: justify">To approve the repricing of options exercisable into ADSs of the Company granted to Mr. Rick Scruggs;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">6.</td><td style="text-align: justify">To approve the extension of options to purchase ADSs of the Company previously granted to members
of the board of directors; and</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"></td><td style="width: 19.85pt">7.</td><td style="text-align: justify">To approve the extension of options to purchase ADSs of the Company previously granted to Mr. Dror
Ben-Asher.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: -19.85pt; margin: 0pt 0 0pt 28.35pt"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">The Company is currently unaware of any other
matters that may be raised at the General Meeting. Should any other matters be properly raised at the General Meeting, the persons
designated as proxies shall vote according to their own judgment on those matters.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">Shareholders may present proposals for consideration
at the General Meeting by submitting their proposals to the Company no later than Sunday, October 18, 2020 in accordance with applicable
law.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Shareholders Entitled to Vote</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">Only holders of ADSs and Ordinary Shares
of record at the close of business on September 22, 2020 (the &ldquo;Record Date&rdquo;), shall be entitled to receive notice of
and to vote at the General Meeting. At the close of business on September 21, 2020, the Company had outstanding 374,086,048 Ordinary
Shares (represented by 37,408,604 ADSs), each of which is entitled to one vote on each of the matters to be presented at the General
Meeting.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Proxies</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">A form of proxy card for use at the General
Meeting is attached to this Proxy Statement and has been sent to the holders of ADSs together with a prepaid return envelope for
the proxy. By executing the proxy card and appointing &ldquo;proxies&rdquo;, holders of ADSs and Ordinary Shares may vote at the
General Meeting, whether or not they attend.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">ADS holders should return their proxies
in the enclosed form to BNY Mellon by the date set forth on the proxy card. If a properly executed proxy is received by the BNY
Mellon by the date set forth on the proxy card, all of the Ordinary Shares represented by the proxy shall be voted as indicated
on the proxy card.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">Shareholders who hold ordinary shares
through members of the Tel-Aviv Stock Exchange Ltd. (&quot;TASE&quot;), who did not convert their ordinary shares to ADSs,
may vote in the General Meeting in person or vote through the attached form of proxy card, which also serves as their voting
card, by completing, dating, signing and mailing the proxy card to the Company&rsquo;s offices so that it is received by the
Company no later than Monday October 26, 2020 at 11:00 a.m. Israel time, and must also provide the Company with a copy of
their identity card, passport or certificate of incorporation (as the case may be), and an ownership certificate confirming
their ownership of the Company&rsquo;s ordinary shares on the Record Date. Such certificate must be approved by a recognized
financial institution, as required by the Israeli Companies Regulations (Proof of Ownership of Shares for Voting at General
Meeting) of 2000, as amended.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">Subject to applicable law and the rules of the NASDAQ Stock Market, in the absence of
instructions, the ADSs and Ordinary Shares represented by properly executed and received proxies will be voted FOR all of the
proposed resolutions to be presented at the General Meeting for which the Board of Directors recommends a &ldquo;FOR&rdquo;.
Holders of ADSs and Ordinary Shares may revoke their proxies at any time before the deadline for receipt of proxies by filing
with the Company (in the case of holders of Ordinary Shares) or with BNY Mellon (in the case of holders of ADSs) a written
notice of revocation or duly executed proxy bearing a later date.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Expenses and Solicitation </b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board of Directors is soliciting proxies
for use at the General Meeting. The Company expects to mail this Proxy Statement and the accompanying proxy cards to ADS holders
on or about October 1, 2020. In addition to solicitation of proxies to holders of ADSs by mail, certain officers, directors, employees
and agents of the Company, may solicit proxies by telephone, mail or other personal contact. The Company shall bear the cost of
the solicitation of the proxies, including postage, printing and handling and shall reimburse the reasonable expenses of brokerage
firms and others for forwarding materials to beneficial owners of ADSs or Ordinary Shares. In addition, we have retained Kingsdale
Advisors (&ldquo;Kingsdale&rdquo;) to assist in the solicitation of proxies.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This proxy statement and proxy card shall also
serve as a voting deed (ktav hatzba&rsquo;a), as such term is defined under the Israel Companies Law 1999 (the &ldquo;Companies
Law&rdquo;).</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Quorum and Voting</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Two or more shareholders holding ADSs or Ordinary
Shares conferring in the aggregate at least twenty-five percent (25%) of the voting power of the Company, present in person or
by proxy at the General Meeting and entitled to vote thereat, shall constitute a quorum. If within half an hour from the time appointed
for the General Meeting a quorum is not present, the General Meeting shall be adjourned to the next business day following the
day of the scheduled meeting, at the same time and place, or at such other day, time and place as shall be prescribed by the Board
of Directors in a notification to the shareholders. At such reconvened meeting, any one (1) shareholder present in person or by
proxy shall constitute a quorum regardless of the number of Ordinary Shares represented.&nbsp;<font style="color: red"><br>
<br>
</font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The approval of Proposals 2, 4, 5 and 6 each
requires the affirmative vote of at least a majority of the voting power represented at the General Meeting, in person or by proxy,
and voting on the matter presented.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The approval of Proposals 1, 3 and 7 each requires
the affirmative vote of at least a majority of the voting power represented at the General Meeting, in person or by proxy, and
voting on the matter presented, provided that one of the following two alternatives must apply: (i) such majority vote at the General
Meeting shall include at least a majority of the total votes of shareholders who are not controlling shareholders of the Company
(as defined in the Companies Law) and do not have a personal interest in the approval of the proposal, participating in the voting
at the General Meeting in person or by proxy, without taking abstentions into account; or (ii) the total number of votes of the
non-controlling shareholders mentioned in clause (i) above that are voted against such proposal does not exceed two percent (2%)
of the total voting rights in the Company.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; color: red">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">For this purpose, &ldquo;personal interest&rdquo;
is defined under the Companies Law as: (1) a shareholder&rsquo;s personal interest in the approval of an act or a transaction of
the Company, including (i) the personal interest of any of his or her relatives (which includes for these purposes the foregoing
shareholder&rsquo;s spouse, siblings, parents, grandparents, descendants, and spouse&rsquo;s descendants, siblings, and parents,
and the spouse of any of the foregoing); (ii) a personal interest of a corporation in which a shareholder or any of his/her aforementioned
relatives serve as a director or the Chief Executive Officer, owns at least 5% of its issued share capital or its voting rights
or has the right to appoint a director or Chief Executive Officer; and (iii) a personal interest of an individual voting via a
power of attorney given by a third party (even if the empowering shareholder has no personal interest), and the vote of an attorney-in-fact
shall be considered a personal interest vote if the empowering shareholder has a personal interest, and all with no regard as to
whether the attorney-in-fact has voting discretion or not, but (2) excludes a personal interest arising solely from the fact of
holding shares in the Company.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; color: red">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; color: red"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; color: red">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0"><b>Please note that you are required to indicate
on the proxy card with respect to Proposals 1, 3 and 7 whether you are a controlling shareholder of the Company, or acting on its
behalf or not, and whether you have a personal interest in the approval of the proposals as provided above or not. If you fail
to so indicate on the proxy card, your vote may not be counted with respect to the proposal(s) for which you failed to provide
notification.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; color: red">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">Shareholders wishing to express their position
on an agenda item for this General Meeting may do so by submitting a written statement (&ldquo;Position Statement&rdquo;) to the
Company&rsquo;s offices, c/o Mr. Micha Ben Chorin, at 21 Ha'arba'a Street, Tel-Aviv, 6473921 Israel. Any Position Statement received,
that is in accordance with the guidelines set by the Israel Companies Law, will be furnished to the U.S. Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) on Form 6-K, and will be made available to the public on the Commission&rsquo;s website
at <u>http://www.sec.gov</u>.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">Position Statements must be submitted to the
Company by no later than Sunday, October 18, 2020.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0"><b>Director Independence</b></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">Our board of directors has determined that
all of the Company&rsquo;s directors are independent for the purposes of the Nasdaq Listing Rules, other than Mr. Dror Ben-Asher
and Mr. Rick Scruggs.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0"><b>Reporting Requirements</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">The Company is subject to the information reporting
requirements of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), applicable to foreign private
issuers. The Company fulfills these requirements by filing reports with the Commission. The Company&rsquo;s filings are available
to the public on the Commission&rsquo;s website at <u>http://www.sec.gov</u>.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">As a foreign private issuer, the Company is
exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements. The circulation of this
notice and proxy statement should not be considered as an admission that the Company is subject to the proxy rules under the Exchange
Act.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 28.35pt; margin: 0pt 1.7pt 0pt 0">THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE <b><i>FOR</i></b>
EACH OF THE PROPOSALS.</p>

<p style="font-size: 10pt; text-indent: 28.35pt; margin: 0pt 1.7pt 0pt 0">&nbsp;</p>

<p style="margin: 0pt 1.7pt 0pt 0; font-size: 10pt; text-indent: 28.35pt">Except as specifically provided herein, the lack
of a required majority for the adoption of any resolution presented shall not affect the adoption of any other resolutions for
which the required majority was obtained.</p>

<p style="margin: 0pt 1.7pt 0pt 0; font-size: 10pt; text-indent: 28.35pt">&nbsp;</p>

<p style="margin: 0pt 1.7pt 0pt 0; font-size: 10pt; text-indent: 28.35pt"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; width: 5%">&nbsp;</td>
    <td style="border-top: Black 1pt solid; width: 90%"><b>&nbsp;</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; width: 5%">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: Black 1pt solid">&nbsp;</td>
    <td style="text-indent: 20pt; padding-left: 0pt"><b>We request
    you to carefully read this entire Proxy Statement, including the documents we refer to in this Proxy Statement. If you have
    any questions, need assistance in voting, or need additional material, please contact our Proxy Solicitation Agent, Kingsdale
    Advisors:</b></td>
    <td style="border-right: Black 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: Black 1pt solid">&nbsp;</td>
    <td><b>&nbsp;</b></td>
    <td style="border-right: Black 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: Black 1pt solid">&nbsp;</td>
    <td style="text-align: center"><b>+ 1 (866) 581-1392 (toll-free
    in North America)</b></td>
    <td style="border-right: Black 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: Black 1pt solid">&nbsp;</td>
    <td style="text-align: center"><b>+1 (416) 867-2272 (collect
    call outside of North America)</b></td>
    <td style="border-right: Black 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: Black 1pt solid">&nbsp;</td>
    <td style="text-align: center"><b>e-mail: contactus@kingsdaleadvisors.com</b></td>
    <td style="border-right: Black 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid"><b>&nbsp;</b></td>
    <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</td></tr>
</table>

<p style="margin: 0pt 1.7pt 0pt 0; font-size: 10pt; text-indent: 28.35pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>PROPOSAL NO. 1</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&nbsp;</b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>AMENDMENT TO THE COMPANY&rsquo;S COMPENSATION POLICY REGARDING
THE D&amp;O INSURANCE PREMIUM</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Under the Companies Law, the terms of employment
and service, which include D&amp;O insurance coverage of officers and directors of public companies, such as the Company, must
be determined in accordance with a directors and officers compensation policy (the &ldquo;Compensation Policy&rdquo;) (except in
limited circumstances set forth in the Companies Law). All companies subject to the Companies Law are required to review and re-approve
their Compensation Policy based on the guidelines specified in the Companies Law every three years.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Compensation Committee and Board of Directors
have approved an amendment to the Compensation Policy to remove the reference to the maximum annual premium that may be paid by
the Company for D&amp;O insurance policies and recommended its approval by the shareholders in light of a leniency recently published
by the Israeli Securities Authority. The proposed amendments to the Compensation Policy as provided in&nbsp;<u>Appendix A</u>&nbsp;are
marked against the current Compensation Policy.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">In recent years, there have been significant
changes in the D&amp;O insurance policy market, in particular due to continued increase in class action lawsuits filed against
companies traded on the U.S. public markets. These changes have caused to numerous major traditional leading D&amp;O insurers to
limit their exposure to claims, leading to significantly increased premiums for D&amp;O insurance policies, and in particular for
companies in the life science sector. As a result of the significantly increased premiums, the Company's Compensation Committee,
followed by the Board of Directors, approved an amendment to the Compensation Policy to remove the limitations on the maximum annual
premium payable under D&amp;O insurance policies (currently US $2 million).</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">It is proposed that at the General Meeting,
the following resolution be adopted:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 1.35pt 0pt 0"><b><i>&ldquo;RESOLVED to approve
an amendment to the Company&rsquo;s Compensation Policy to remove the limitations on the maximum annual premium payable under D&amp;O
insurance policies.&rdquo;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 29.8pt 0pt 35.45pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">The affirmative vote of at least a majority
of the voting power represented at the General Meeting, in person or by proxy, and voting on the matter presented, is required
for shareholders to approve this resolution provided that either: (i) such majority vote at the General Meeting shall include at
least a majority of the total votes of shareholders who are not controlling shareholders of the Company (as defined in the Companies
Law) and do not have a personal interest in the approval of the proposal, participating in the voting at the General Meeting, in
person or by proxy, without taking abstentions into account; or (ii) the total number of votes of the non-controlling shareholders
mentioned in clause (i) above that are voted against such proposal does not exceed two percent (2%) of the total voting rights
in the Company.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0"><b>THE COMPENSATION COMMITTEE AND BOARD OF
DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS VOTE FOR THE APPROVAL OF THE AMENDMENT TO THE COMPENSATION POLICY.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in"><b></b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>PROPOSAL NO. 2</b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION
OF THE COMPANY TO ADD A FORUM SELECTION PROVISION</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><font style="text-transform: uppercase"><b></b></font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">Currently, our Articles
of Association (the <b>Articles</b>&rdquo;) do not include a&nbsp;forum&nbsp;selection&nbsp;provision. In response to a March 2020
decision in the Delaware Supreme Court validating federal&nbsp;forum&nbsp;selection&nbsp;provisions, the Board of Directors considered
the adoption of an exclusive&nbsp;forum&nbsp;selection&nbsp;provision. In light of this Delaware Supreme Court decision in&nbsp;Salzburg
et al. v. Matthew Sciabacucchi, No. 346, 2019 (Del.) and additional considerations discussed below, our Board of Directors has
determined that it is in the best interests of the Company to include an exclusive&nbsp;forum&nbsp;selection&nbsp;provision in
our Articles. For avoidance of any doubt, the Amendment is not being proposed in anticipation of any specific litigation or transaction.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">The Company is seeking
shareholder approval to amend our Articles to add a new section to the Articles to provide that, unless we consent in writing to
<font style="background-color: white">the&nbsp;selection&nbsp;of an alternative&nbsp;forum: (i) the federal district courts of
the United States shall be the exclusive forum for the resolution of any claim arising under the Securities Act of 1933, as amended
(the &ldquo;federal forum selection provision&rdquo;); and (ii) the Tel Aviv District Court (Economic Division) shall be the exclusive
forum for (a)&nbsp;any derivative action or proceeding brought on behalf of the Company, (b)&nbsp;any action asserting a claim
of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company&rsquo;s
shareholders, or (c)&nbsp;any action asserting a claim arising pursuant to any provision of the Israeli Companies Law 5759-1999
or the Israeli Securities Law 5728-1968 (the &ldquo;Israeli forum selection provision&rdquo;) (together, the &ldquo;<b>Amendment</b>&rdquo;).</font></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">Any person or entity
purchasing or otherwise acquiring&nbsp;or holding&nbsp;any interest in&nbsp;shares of capital stock&nbsp;of the Company shall be
deemed to have notice of and consented to these provisions.</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">The Company believes
that adopting the Amendment is in the best interests of the Company and its shareholders for the following reasons: <font style="background-color: white">(i)
the federal forum selection provision allows for the consolidation of multi-jurisdiction litigation and reduces the risk that the
outcome of cases in multiple jurisdictions could be inconsistent</font>; (ii) the <font style="background-color: white">Amendment
will help avoid state court forum shopping and provide for efficiencies in managing the procedural aspects of securities litigation;
and (iii) the Amendment provides that all intra-corporate disputes be litigated in the State of Israel, where the Company is incorporated
and whose law governs such disputes. Moreover, the Israeli courts have developed considerable expertise in dealing with corporate
law issues involving Israeli public companies, as well as a substantial and influential body of case law construing Israel&rsquo;s
corporate law and long-standing precedent regarding corporate governance.</font></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white"><font style="background-color: white">The
Amendment will only regulate the&nbsp;forum&nbsp;where shareholders may file certain claims; it does not restrict the ability of
our shareholders to bring such claims, nor does it affect the remedies available if such claims are successful. Moreover, the Company
will retain the ability to consent to an alternative&nbsp;forum&nbsp;in circumstances where the Company determines that its interests
and those of its shareholders are best served by permitting a particular dispute to proceed in a&nbsp;forum&nbsp;other than the
federal district courts or State of Israel, as applicable.</font></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white"><font style="background-color: white">Given
these considerations, the Board of Directors has determined that it is in the best interests of the Company that the Articles be
amended to include these exclusive&nbsp;forum&nbsp;selection&nbsp;provisions. There is, however, uncertainty as to whether a court
would enforce these provisions. In addition, although we are seeking approval of these provisions for the reasons cited above,
if these provisions are approved and implemented, this Amendment may also have the effect of limiting investors&rsquo; ability
to bring a claim in a judicial&nbsp;forum&nbsp;that they find favorable.</font></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0; background-color: white"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">If approved, the amendment
would enable us to amend our Articles by adding a new Article 38 to the Articles to read as follows:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0; background-color: white"><b></b></p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><b>FORUM
SELECTION</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 15.5pt 0pt 14.2pt; background-color: white"></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 15.5pt 0pt 14.2pt; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 15.5pt 0pt 14.2pt; background-color: white">38.
Unless the Company consents in writing to the&nbsp;selection&nbsp;of an alternative&nbsp;forum, and other than with respect to
plaintiffs or a class of plaintiffs which may be entitled to assert in the courts of the State of Israel, with respect to any causes
of action arising under the Securities Act of 1933 as amended, the federal district courts of the United States of America shall
be the exclusive&nbsp;forum&nbsp;for the resolution of any complaint asserting a cause of action arising under the Securities Act
of 1933, as amended; and (b) unless the Company consents in writing to the&nbsp;selection&nbsp;of an alternative&nbsp;forum, the
Tel Aviv District Court (Economic Division) shall be the exclusive&nbsp;forum&nbsp;for (i)&nbsp;any derivative action or proceeding
brought on behalf of the Company, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any director, officer
or other employee of the Company, to the Company or the Company&rsquo;s shareholders, or (iii)&nbsp;any action asserting a claim
arising pursuant to any provision of the Israeli Companies Law 5759-1999 or the Israeli Securities Law 5728-1968. Any person or
entity purchasing or otherwise acquiring&nbsp;or holding&nbsp;any interest in&nbsp;shares of the Company shall be deemed to have
notice of and consented to these provisions.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 15.5pt 0pt 14.2pt; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0; background-color: white"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">It is proposed that
at the General Meeting the following resolution be adopted:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&ldquo;<b><i>RESOLVED,
to amend the Company&rsquo;s Amended and Restated Articles of Association to add a federal forum selection provision and an Israeli
forum selection provision, as described in the Proxy Statement.</i></b>&rdquo;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The affirmative vote of at least a majority
of the voting power represented at the General Meeting, in person or by proxy and voting thereon, is required to adopt this resolution.</p>

<p style="font-size: 10pt; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><font style="text-transform: uppercase"><b>The
Board of Directors recommend THAT THE SHAREHOLDERS VOTE FOR the approval of AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION
OF THE COMPANY. </b></font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>PROPOSAL NO. 3</b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0; background-color: white"><b>AMENDMENTS TO THE EMPLOYMENT TERMS OF
MR. DROR BEN-ASHER, THE COMPANY&rsquo;S CHIEF EXECUTIVE OFFICER</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0; background-color: white"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Companies Law requires that the terms of
service and employment of a company&rsquo;s chief executive officer be approved by the compensation committee, the board of directors
and the shareholders of the company, except in the limited circumstances set forth in the Companies Law.&nbsp;In addition, the
Companies Law provides that transactions between a company and its directors regarding their terms of office as director, and with
respect to their terms of employment in other positions in the company, are subject to the approval of such company's Compensation
Committee, as applicable, board of directors and shareholders.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Mr. Dror Ben-Asher has served as the Company's
Chief Executive Officer and Chairman of the Board of Directors since its incorporation until today. In light of Mr. Ben-Asher's
contribution to the Company, and in accordance with the Compensation Policy, the Compensation Committee and Board of Directors
have determined that the proposed revisions to the terms of employment described below are appropriate, reasonable and reflect
the significant contribution of Mr. Ben-Asher to the Company.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">When discussing revisions to the terms of
employment of Mr. Ben-Asher, the Compensation Committee and the Board of Directors took into consideration, inter alia: (a) the
Board of Directors considers Mr. Ben-Asher as a major factor in setting the Company's business strategy and a key factor for the
Company's successful business execution; (b) the Company's achieved strategic milestones during the last years as a results of
Mr. Ben-Asher's leadership and contribution; (c) Mr. Ben-Asher's fixed compensation has not been updated for the last three years
and reflect significantly lower compensation than market benchmark; and (d) Mr. Ben-Asher also serves as the Chairman of the Board
of Directors with no additional compensation. The proposed revised terms of compensation which will be effective starting on October
1, 2020, comply with the Company&rsquo;s Compensation Policy.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Compensation Committee and Board found its
advisable and appropriate to recommend to the shareholders to provide for a revision to the terms of employment of Mr. Ben-Asher
as follows (i) an increase of the annual base salary of Mr. Ben-Asher from NIS 1,260,000 ($360,000 based on the representative
U.S. dollar&nbsp;<i>&ndash;</i>&nbsp;NIS rate of exchange of 3.5) to NIS 2,310,000 ($660,000 based on the representative U.S. dollar&nbsp;<i>&ndash;</i>&nbsp;NIS
rate of 3.5); (ii) increased benefits relating to advance notice of termination (increase from six months to 12 months), company
car reimbursement expenses (increased from NIS 6,000 monthly to NIS 7,500 monthly), annual medical checkup, and medical private
insurance for a cost of up to $1,000 annually and (iii) to incorporate the terms of the change in control employee retention plan
(the &quot;<b>CIC Plan</b>&quot;) in Mr. Ben-Asher&rsquo;s employment terms as described below.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">In 2018, the Company adopted the CIC Plan,
providing for payment to Company employees, other than to the chief executive officer, in the event of a &ldquo;Change in Control&rdquo;
events (as defined below), subject to the satisfaction of various conditions. Compensation to employees would be in amount of up
to 12&nbsp;months&rsquo; salary depending on employee seniority and&nbsp;years with the Company.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">A &ldquo;Change in Control&rdquo; under the
CIC Plan is defined as follows:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 36pt">i.</td><td style="text-align: justify">The consummation of any merger, consolidation, reorganization, or similar transaction or series
of related transactions of the Company with another entity, other than a merger, consolidation, reorganization, or similar transaction
or series of related transactions which would result in the shareholders of the Company immediately preceding the transaction beneficially
owning, immediately after the transaction, at least 50% of the combined voting power of the outstanding securities of the surviving
or resulting entity (or its parent);</td></tr></table>

<p style="margin: 0pt 0 0pt 71.45pt; font-size: 10pt; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 36pt">ii.</td><td style="text-align: justify">Any &ldquo;person&rdquo; (as such term is used in Sections 13(d) and 14(d) of the U.S. Exchange
Act of 1934 (&ldquo;Exchange Act&rdquo;)) or &ldquo;group&rdquo; (two or more persons acting as a partnership, limited partnership,
syndicate or other group for the purpose of acquiring, holding, or disposing of the applicable securities referred to herein) becomes
the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the
Company representing fifty percent (50%) or more of the total voting power represented by the Company&rsquo;s then-outstanding
voting securities;</td></tr></table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 36pt">iii.</td><td style="text-align: justify">The election of a board of directors over a three-year period or less, the majority of which is
not supported by at least a majority of the then existing board of directors of the Company; or</td></tr></table>

<p style="margin: 0pt 0 0pt 71.45pt; font-size: 10pt; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 36pt">iv.</td><td style="text-align: justify">Any sale, lease, exchange, or other transfer (in one transaction or a series of related transactions)
of all or substantially all of the assets of the Company (other than to an entity controlled by the Company).</td></tr></table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">The benefits under the CIC Plan will be paid
if the Company&rsquo;s total equity value will be at least $250 million at the time of the Change in Control event, and the payment
will depend on the employee's continued employment with the Company as follows: (i) in case of termination of employment (by the
Company) during the first year after the Change in Control event the payment will be paid at the end of the employment period;
and (ii) otherwise at the end of the period agreed with the new controlling shareholder (but not more than two years).</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">The CIC Plan provides that payment to
top management shall not exceed an amount equal to six months&rsquo; salary for management that has been employed by the
Company less than three years at the time of the occurrence of the Change in Control and an amount not to exceed 12
months&rsquo; salary for management that has been employed by the Company for more than three years at the time of the
occurrence of the Change in Control event. Due to the importance of Mr. Ben-Asher to the success of the Company and his key
role in leading the Company, the Board of Directors and Compensation Committee find it advisable and appropriate to recommend
to the shareholders to approve an amendment to the employment terms of Mr. Ben-Asher to provide for a payment equal to total
of 18 months&rsquo; salary upon the occurrence of a Change in Control. Mr. Ben-Asher has been employed by the Company since
2009<font style="color: windowtext">.</font></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">It is proposed that at the General Meeting the
following resolution be adopted:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt"><b><i>&nbsp;</i></b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt"><b><i>&ldquo;RESOLVED, to approve the amendments
to the employment terms of Mr. Dror Ben-Asher as described in the proxy statement&rdquo;.</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent">The affirmative
vote of at least a majority of the voting power represented at the General Meeting, in person or by proxy, and voting on the matter
presented, is required for shareholders to approve this resolution provided that either: (i) such majority vote at the General
Meeting shall include at least a majority of the total votes of shareholders who are not controlling shareholders of the Company
(as defined in the Companies Law) and do not have a personal interest in the approval of the proposal, participating in the voting
at the General Meeting, in person or by proxy, without taking abstentions into account; or (ii) the total number of votes of the
non-controlling shareholders mentioned in clause (i) above that are voted against such proposal does not exceed two percent (2%)
of the total voting rights in the Company.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><font style="text-transform: uppercase"><b>The
COMPENSATION COMMITTEE AND THE Board of Directors recommend THAT THE SHAREHOLDERS VOTE FOR the approval of the AMENDMENTs TO EMPLOYMENT
TERMS OF MR. DROR BEN-ASHER. </b></font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in"><b></b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>PROPOSAL NO. 4</b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>AMENDMENT TO THE EMPLOYMENT TERMS OF MR. RICK SCRUGGS, THE COMPANY
CHIEF COMMERCIAL OFFICER</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b></b>&nbsp;<br>
</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Companies Law provides that transactions
between a company and its directors regarding their terms of office as director, and with respect to their terms of employment
in other positions in the company, are subject to the approval of such company&rsquo;s audit committee or compensation committee,
as applicable, board of directors and shareholders.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Mr. Rick D. Scruggs has served as the Company&rsquo;s
Chief Commercial Officer since February 2020 and has served as its Chief Operations Officer, U.S. Operations since January&nbsp;1,
2019 and as a member of the Board of Directors since January&nbsp;1, 2016. Mr. Scruggs has significant business development and
commercial experience in the biopharma industry, including as the former Executive Vice President of Business Development at Salix
Pharmaceuticals.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">As described in Proposal 3 above, the Company
adopted in 2018 the CIC Plan providing for payment to Company employees, other than to the chief executive officer, in &ldquo;Change
in Control&rdquo; events, subject to the satisfaction of various conditions. Compensation to employees would be up to 12&nbsp;months&rsquo;
salary depending on employee seniority and&nbsp;years with the Company. The terms of the CIC are summarized in Proposal 3 above.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 35.45pt">Due to the importance of Mr. Scruggs to the
success of the Company, the Compensation Committee and Board of Directors find it advisable and appropriate to recommend to the
shareholders to approve an amendment to the employment terms of Mr. Scruggs to incorporate the terms of the CIC Plan. Under the
terms of the CIC Plan, Mr. Scruggs would be entitled to a payment upon a Change in Control equal to six months&rsquo; salary if
he is employed by the Company less than three years at the time of the occurrence of the Change in Control event and a payment
equal to 12 months&rsquo; salary if he is employed by the Company for more than three years at the time of the occurrence of the
Change in Control event. Mr. Scruggs has been employed by the Company since January 2019.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">It is proposed that at the General Meeting the
following resolution be adopted:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 1.35pt 0pt 0; background-color: transparent"><b><i>&ldquo;RESOLVED,
to approve the amendment to the employment terms of Mr. Rick D. Scruggs as described in the proxy statement<font style="background-color: white">.</font>&rdquo;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 29.8pt 0pt 0; background-color: transparent"><font style="font-weight: normal"><i>&nbsp;</i></font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The affirmative vote of at least a majority
of the voting power represented at the General Meeting, in person or by proxy and voting thereon, is required to adopt this resolution.</p>

<p style="font-size: 10pt; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><font style="text-transform: uppercase"><b>The
compensation committee and the Board of Directors recommend a vote FOR the approval of Amendment to the employment terms of Mr.
Scruggs.</b></font></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>PROPOSAL NO. 5</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>REPRICING OF OPTIONS EXERCISABLE INTO ADSs OF THE COMPANY PREVISOLY
GRANTED TO MR. RICK SCRUGGS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Earlier this year, the Compensation Committee
and the Board of Directors approved the repricing of all options to purchase ADSs that were outstanding at the time of such approval
in order to incentive the Company's officers, team members and consultants to continue to contribute to the Company's success and
results of operations. This was due to the fact that the exercise price of each option to purchase ADSs granted by the Company
under the RedHill Biopharma Ltd. Amended and Restated Award Plan (2010) (the &quot;Plan&quot;) exceeded the then current price
per ADS on the Nasdaq. On May 4, 2020, the Company shareholders approved the repricing of the options held by Mr. Scruggs and the
Company directors immediately prior to the date of that shareholders meeting as required under the Israeli Companies Law 5759-1999
(&quot;Companies Law&quot;) on the same terms as the Company employees.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The repricing plan, previously approved by
the Compensation Committee and the Board, provided that each of the existing options would be repriced to an exercise price
(called, the &ldquo;Updated Exercise Price&rdquo;) equal to fifty percent (50%) of the original exercise price of each such
option, but not less than $6.00; provided that (x) the exercise price will lowered to $5.00 if the Company generates (a) at
least $75 million of net revenues&nbsp;<u>or</u>&nbsp;negative Earnings Before Interest, Taxes, Depreciation and Amortization
(&ldquo;EBITDA&rdquo;) of less than $55 million in 2020; (b) at least $100 million of net
revenues&nbsp;<u>or</u>&nbsp;negative EBITDA of less than $40 million in 2021; or (c) at least $130 million of net
revenues&nbsp;<u>or</u>&nbsp;negative EBITDA of less than $20 million in 2022, and (y) the exercise price will lowered to
$4.30, if the Company generates (a) at least $75 million of net revenues <u>and</u> negative EBITDA of less than $55
million in 2020; (b) at least $100 million of net revenues <u>and</u> negative EBITDA of less than $40 million in 2021; or
(c) at least $130 million of net revenues&nbsp;<u>and</u>&nbsp;negative EBITDA of less than $20 million in 2022.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Following the last shareholders meeting, the
Compensation Committee and the Board of Directors approved the repricing of the options that had been granted under the Plan since
their previous approvals of the repricing of options. In the context of this recent approval of the repricing, the Compensation
Committee and the Board also approved the repricing of options to acquire 75,000 ADSs granted to Mr. Scruggs (which has an exercise
price of $6.84) on the same terms as the repricing of options approved for other grantees who were granted options under the Plan
during this period; provided that the Updated Exercise Price of these options held by Mr. Scruggs shall not be less than the closing
price per share on the date of the General Meeting. As with all other optionees, Mr. Scruggs would need to accept the terms of the repricing for it to be effective. </p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">It is proposed that at the General Meeting,
the following resolution be adopted:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><b><i>&quot;RESOLVED, to approve the repricing
of the options to acquire 75,000 ADSs granted to the Mr. Rick Scruggs on the terms described in the proxy statement.&quot;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; color: red"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The affirmative vote of at least a majority
of the voting power represented at the General Meeting, in person or by proxy and voting thereon, is required to adopt this resolution.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0"><b>THE COMPENSATION COMMITTEE AND THE BOARD
OF DIRECTORS RECOMMEND THAT YOU VOTE FOR THE APPROVAL OF THE REPRICING OF OPTIONS GRANTED TO MR. SCRUGGS.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>PROPOSAL NO. 6</b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>EXTENSION OF OPTIONS TO PURCHASE ADSs OF THE COMPANY PREVIOUSLY
GRANTED TO BOARD OF DIRECTORS MEMBERS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">On March 19, 2014, the Company granted options
to purchase an aggregate of 64,000 ADSs at an exercise price of $14.80 per ADS to the members of the Board of Directors pursuant
to the Plan (the &quot;<b>2014 Options</b>&quot;) which options expire seven years following the grant date. In order to incentivize
and reward them for their dedication and commitment to the Company, the Company's Compensation Committee and the Board of Directors
approved the extension of the exercise period for the 2014 Options by three additional years until March 19, 2024. Following such
extension, the term of the 2014 Options will have the maximum term permitted under the Plan and may not be further extended.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">The proposed extension of the 2014 Options would
be on the same terms as the current terms and conditions of the 2014 Options.</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">It is proposed that at the General Meeting,
the following resolution be adopted:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 21.3pt; margin: 0pt 0"><b><i>&quot;RESOLVED, to approve the extension
until March 19, 2024 of the exercise period of options to purchase 64,000 ADSs granted to the members of the Board of Directors,
with all other terms remaining unchanged.&quot; </i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The affirmative vote of at least a majority
of the voting power represented at the General Meeting, in person or by proxy and voting thereon, is required to adopt this resolution.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0"><b>THE COMPENSATION COMMITTEE AND THE BOARD
OF DIRECTORS RECOMMEND THAT YOU VOTE FOR THE APPROVAL OF EXTENSION OF OPTIONS GRANTED TO THE BOARD MEMBERS.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 2in"><b></b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>PROPOSAL NO. 7</b></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>EXTENSION OF OPTIONS TO PURCHASE ADSs OF THE COMPANY PREVIOUSLY
GRANTED TO MR. DROR BEN-ASHER</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Companies Law requires that the terms of
service and employment of a company&rsquo;s chief executive officer be approved by the compensation committee, the board of directors
and the shareholders of the company, except in the limited circumstances set forth in the Companies Law.&nbsp;In addition, the
Companies Law provides that transactions between a company and its directors regarding their terms of office as director, and with
respect to their terms of employment in other positions in the company, are subject to the approval of such company's audit committee
or Compensation Committee, as applicable, board of directors and shareholders.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">On March 19, 2014, the Company granted options
to purchase 45,000 ADSs to Mr. Ben-Asher at an exercise price of $14.80 per ADS, which options expire seven years following the
grant date. In order to incentivize Mr. Ben-Asher and to reward him for his dedication and commitment to the Company, the Company's
Compensation Committee and the Board of Directors approved the extension of the exercise period of such options by three additional
years until March 19, 2024. Following such extension, the term of the options will have the maximum term permitted under the Plan
and may not be further extended.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">The proposed extension of the options would
be on the same terms as the current terms and conditions of the options.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in"><b></b></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">It is proposed that at the General Meeting,
the following resolution be adopted:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 21.3pt; margin: 0pt 0"><b><i>&quot;RESOLVED, to approve the extension
until March 19, 2024 of the exercise period of options to purchase 45,000 ADSs granted to Mr. Ben-Asher, with all other terms remaining
unchanged.&quot; </i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 21.3pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">The affirmative vote of at least a majority
of the voting power represented at the General Meeting, in person or by proxy, and voting on the matter presented, is required
for shareholders to approve this resolution provided that either: (i) such majority vote at the General Meeting shall include at
least a majority of the total votes of shareholders who are not controlling shareholders of the Company (as defined in the Companies
Law) and do not have a personal interest in the approval of the proposal, participating in the voting at the General Meeting, in
person or by proxy, without taking abstentions into account; or (ii) the total number of votes of the non-controlling shareholders
mentioned in clause (i) above that are voted against such proposal does not exceed two percent (2%) of the total voting rights
in the Company.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><font style="text-transform: uppercase"><b>The
Compensation Committee and the Board of directors recommend a vote FOR the approval of extension of options to acquire Ads</b></font><b>s
<font style="text-transform: uppercase">of Mr. Dror Ben-Asher.</font></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0; background-color: transparent"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 35.45pt; margin: 0pt 0">Other than as set forth above, as of the mailing
of this Proxy Statement, management knows of no other business to be transacted at the General Meeting, but, if any other matters
are properly presented at the General Meeting, the persons named in the enclosed form of proxy will vote upon such matters in accordance
with their best judgment.</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0"><b>By order of the Board of Directors </b></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0"><b>Dror Ben-Asher</b></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0"><b>Chairman of the Board of Directors<br>
Dated: September 22, 2020</b></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Appendix A &ndash; Amendment to the Compensation Policy</b></p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0 0pt 19.85pt; text-align: left; text-indent: -19.85pt"><u>Exemption, Indemnification and
Insurance</u></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 32.55pt 0pt 45.7pt"><u>Board member and Officer liability insurance
(claims made):</u> the Company may obtain a liability insurance policy for Board members and Officers, which would apply to Officers
of the Company and/or of its subsidiaries, as they may be, from time to time, subject to the following terms and conditions: (a)
the total insurance coverage under the insurance policy shall not exceed US $100 million; <strike>(b) the annual premium payable
by the Company for the insurance premium shall not exceed US $2 million annually</strike> and (b<strike>c</strike>) the purchase
of such policy shall be approved by the Compensation Committee (and, if required by law, by the Board) which shall determine that
such policy reflects the current market conditions, and it shall not materially affect the Company's profitability, assets or
liabilities.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 32.5pt 0pt 45.7pt"><u>Board member and Officer&rsquo;s liability insurance
(run-off):</u> should the Company sell its operations (in whole or in part) and/or in case of merger, spin-off or any other significant
business combination involving the Company and/or part or all of its assets, the Company may obtain a Board member and Officer&rsquo;s
liability insurance policy (run-off) for Board members and Officers in office with regard to the relevant operations, subject
to the following terms and conditions: (a) the insurance term shall not exceed 7 years; (b) the coverage amount shall not exceed
US $100 million; <strike>(c) the premium payable by the Company shall not exceed US $2 million annually</strike> and (c<strike>d</strike>)
the purchase of such policy shall be approved by the Compensation Committee (and, if required by law, by the Board) which shall
determine that such policy reflects the current market conditions, and it shall not materially affect the Company's profitability,
assets or liabilities.</p>

<p style="font-size: 10pt; text-align: left; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="exh991_01.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; font-size: 1px; color: White">12179 RedHill  Biopharma  Ltd VIF Proof 2 For  Against Abstain For  Against Abstain MAIL &#8226; Mark, sign and date your Voting Instruction Form. &#8226; Detach  your  Voting  Instruction Form. &#8226; Return  your  Voting  Instruction  Form  in  the   postage - paid  envelope provided. Extraordinary  General  Meeting  of  RedHill Biopharma  Ltd.   to be  held  on  October  26, 2020 For  Holders as  of  September  22, 2020 All votes must be received by 12:00 p.m. EST, on October 22, 2020. Copyright  &#169;  2020  Mediant Communications  Inc.  All  Rights Reserved Please  Sign Here Please  Date Above Please  Sign Here Please  Date Above   Please separate carefully at the perforation and return just this portion in the envelope provided.   Authorized Signatures  - This  section must  be   completed  for  your  instructions  to be executed. EVENT # CLIENT # PROXY  TABULATOR FOR   REDHILL BIOPHARMA LTD. P.O.  BOX 8016 CARY,  NC 27512 - 9903 1. To approve an amendment to the Company&#8217;s Compensation Policy regarding the D&amp;O insurance premium ; 1 a . Are you a controlling shareholder or do you have a personal interest in the approval of proposal 1 above? (Response required for vote to be counted . ) 2. To  approve  an  amendment  to  the  Amended  and Restated  Articles of  Association  of  the  Company  to  add  a  forum selection provision; 3. To  approve amendments  to  the  employment  terms  of Mr.  Dror Ben - Asher,  the   Company&#8217;s  Chief Executive Officer; 3 a . Are you a controlling shareholder or do you have a personal interest in the approval of proposal 3 above? (Response required for vote to be counted . ) 4. To  approve  an  amendment  to  the  employment  terms  of Mr.  Rick Scruggs,  the   Company&#8217;s  Chief Commercial Officer; 5. To  approve  the  repricing  of  options  exercisable  into  American  Depository  Shares   (&#8220;ADSs&#8221;)  of  the  Company  granted  to Mr.  Rick Scruggs; 6. To  approve  the  extension  of  options  to  purchase  ADSs  of  the  Company   previously  granted  to  members  of  the  board  of  directors; and 7. To  approve  the  extension  of  options  to  purchase  ADSs  of  the  Company   previously  granted  to Mr.  Dror Bern - Asher. 7 a . Are you a controlling shareholder or do you have a personal interest in the approval of proposal 7 above? (Response required for vote to be counted . ) For  Against Abstain Yes No Yes No Yes No Date: Extraordinary General  Meeting  of   RedHill Biopharma Ltd. October  26, 2020 See  Voting  Instruction  On  Reverse Side. Please  make  your  marks  like  this:    Use pen only 12179  RedHill Biopharma  Ltd  VIF.indd 1 9/17/2020 5:40:30 PM</P>

<!-- Field: Page; Sequence: 16; Options: NewSection; Value: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt"></P></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->
<p style="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="exh991_02.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; font-size: 1px; color: White">12179 RedHill  Biopharma  Ltd VIF Proof 2 REDHILL BIOPHARMA LTD. Instructions to The Bank of New York Mellon, as Depositary (Must be received prior to 12 : 00 p . m . EST on October 22 , 2020 ) The undersigned registered owner of American Depositary Shares hereby requests and instructs The Bank of New York Mellon, as Depositary, to endeavor, in so far as practicable, to vote or cause to be voted the amount of Shares or other Deposited Securities represented by such Shares of RedHill Biopharma Ltd . registered in the name of the undersigned on the books of the Depositary as of the close of business on September 22 , 2020 at the Extraordinary General Meeting of the Shareholders of RedHill Biopharma Ltd . to be held on October 26 , 2020 or any postponement or adjournment thereof in respect of the resolutions specified on the reverse . NOTES: 1. Please direct the Depositary how it is to vote by placing an &#8220;X&#8221; in the appropriate box opposite each agenda item . 2. If you do not vote or if your voting instructions are not received before the deadline, you will be deemed to have given a discretionary proxy to the Company to vote the shares represented by your ADRs pursuant to the terms and conditions of the ADRs and the Deposit Agreement under which they are issued . PROXY  TABULATOR FOR REDHILL  BIOPHARMA LTD. P.O.  BOX 8016 CARY,  NC 27512 - 9903 12179  RedHill Biopharma  Ltd  VIF.indd 2 9/17/2020 5:40:31 PM</P>



<p style="margin: 0pt 0; font-size: 10pt; text-align: left"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center">15</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: left"></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>exh991_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exh991_01.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ++ X\# 2(  A$! Q$!_\0
M'0 !  (# 0$! 0            4& P0' @$("?_$ %<0  $# P,"! ,$! 8/
M!08& P$  @,$!1$&$B$3,0<B05$487$5(S*!%D)2D3-B<I.QTA<D-#5457-T
M@I*4H;+!TP@80U.S)38W8]'P1%9DA*+#@Z/A_\0 %@$! 0$
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MI):KP<KM1VB26DEFM?QD#@1NC+F!P_,97O4-YNMO\(9;S;C%+<X;4VJ,D[L
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MS9(W1N:1[M< 1P01[@@H.:^.444ETT<:H4'PK*N<R.N%&:JG:.@X#?&",\X
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MZ@.A.Z4R&0L#0.IEQ;N_9X5M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 7/\
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M%UDH7VVNJXJ.,"J@+RX#9G#' ' <%T9$&E9+93V:ST5LHFEM+1PL@B!Y.UH
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MV- X P!^060]EX@FCJ(FRP2,DC=V<QP(/YA!K5 F96"6*,2-,>T^;&.5Y?\
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M<$@^; R,]QGN6[FN\:BLVK;MK6M^S*^HHK/&^D)S4R1ME9OC=*U@:.#M:_S
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M(/;(Z+Q@$\\'!R %;@LGB"VZNJ'7$MW[83)NB>.FV6I(.S ;DM?!D@9PUWL
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M,;G<'\7WPP/S^2"_(J/6:QGMVHKC2U4+)*."801]-CNHY[FTNWU.[S5!S@<
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M#(_ESNP&3W)08X[;11/#HZ6!CFYP6Q@$<8]O8 )#;:*")D4-+!'$QKFM8R,
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M4?A+H:"[OI:D&IAC%53 QL;'*V';*<ES=FZ0G)<#M'(RNKK :.E/>FA/)/\
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MXP!FX>N>IEV<\#T)[;<>F-0BYQSOO+G0LFZFSKR#<.M XY';F..5NWL-WS.
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MW;SZ...1W!4\@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M''8D'YK:BMFL.@Y\E<_KMBC$;>H-I?F;=NX^<)SS^'LX9:Z0EU;))J^DLE+
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M>2-[F!A=C.2!B5GOSN'H"0O6$P%1&^(E,:CHFAG:\EC!ES3YWF4,;QSSTB.
M3ES0 25AI_$NDF89!0U#8RYS&%Q W/ &!CTW.<QH]27=AZAT%%\;RT9[KZ@(
MB(,$])'-()'&0/ VY9(YO'Y$+PVAB;)')F8N8<MW3/< <$=B<=B4GEG^*$4
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M+:+)5,?+3T]/.QTSWEP=O'4W.W^I \Q?D>^<A>Q9K/04=7FF@AII83'4.<[
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MVQDXQ[9*EE!:*JIZG3= ZJI#2R-A8W;]WM<-HPYO3<YNWVP?R 4Z@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M1DQ2'M-Y^' #(QW&<C.2@M%*R2*GC9-+UI6M =)M#=Q]\#LL5T_O95_Y%_\
MPE>J&*:"E9'4U+JF5N=TKFM:7<^S0!\OR7NIB$]-+"20)&EA(],C"#G--_<\
M7\@?T+(IUFDWL8UHN+\ 8'W35]_15_\ C%_\TU6B!13WZ*O_ ,8O_FFI^BK_
M /&+_P"::E$"BGOT5?\ XQ?_ #34_15_^,7_ ,TU*(%%/?HJ_P#QB_\ FFI^
MBK_\8O\ YIJ40**>_15_^,7_ ,TU/T5?_C%_\TU*(%%/?HJ__&+_ .::GZ*O
M_P 8O_FFI1 HI[]%7_XQ?_--3]%7_P",7_S34H@5+:/_ +\U?^0;_P 16Q^B
MK_\ &+_YIJW['8_LRJFG=4NG=(P,P6!H !)_YI1,HB* B*,;55TE55QT]/3/
MC@D# Y\[F$Y8UW8,/[7N@DT6AU+I_@E%_M3O^FOK)+D7-#Z6D:W/)%2XD#Z=
M-!O(@SCGNB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(BUJEU
M8V0?"PT\C,<F28L(/T#"@V46AU;G_@E%_M3O^FO)JZR.IIHZFFIV,G>8PZ.<
MO(.USNQ8/V3ZH)%$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!%0J/7
M5TN%_KJ&VZ6FJ**BKW4$U;\?"P-+2-SMCB'$ .!P%CA\3*>6QV^L;;9375=V
M^QS1"4%T<P>YKB78Y  W=NQ"#H**A:9UU=-05[12Z6F;:C52TQKG5\.!TWN8
MYW3SO[M[86E8/%NV7O3,%UIZ.5LSKC#;YJ1T@WQ&60-8_..6D'/[QZ(.E(J#
M:=<7FNU?+89=(5%.^ ,DJ)C7PN$43RX-?@'G.T\#E3>M-7VW24%')<Y8FFJF
MZ3&OE;&< $N=SZ #]Y';*"QHHW35WBOUAM]TIPT1U<#)@UKP_;N&=N1W(['Y
MA22 B(@(B("(B B(@(B("T+;_=ET_P Y;_Z,:WUIT$;V55Q<]N&R3AS#[CI,
M&?W@_N0;B(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB M"Y?W7:_\ .3_Z,BWUH7/^Z[5_G)_]&1!OHB("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B A[%$0<A@T#?*/55UN++)HVX1U5S?7155=U#50M);@ B,@$8
MR,'N5OV_PXJZ;Q7GU"ZHIC8^I)6P4@)WMJY(V1O>1C&"&N.<YR5T]$'(=):
MOEBO,<TMDT;4,%?)4&X.,AK6QOE+N#T\;@'8'...ZTV>$5RAM6CS2U='#<[9
M/#]H[7NZ55!'/U6@>7)<T_AR!^(C.,+M2(*U;K%54VO[Q?)'PFDK**GIHVAQ
MWAT;I"XD8QCSC'/NH+Q:T-7:RCHOL^M%.ZFBJ0&OD+6F1\3F,/#7<9<0?D3Z
MKH2(-.S6^*U6NEH8'/='3QMB:YYRX@#&2>.5N(B B(@(B("(B B(@(B("(B
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M41?3SRNA<W<"9&&%H/(X>,M:>%*MU?=*ZQ:/JJ&"C@J;Y&7R"9KI&18IGR\
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M878<>[O4C/&]W8^O.>$&QFY@?P=&3_E7?U5GI35EQ^*9 UN..F\N.?S 6PB
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M1$# ]DP/9$0,!,#V1$# ]@F B(/C6-8T-:UK0/0#"^X ]$1 3 ]D1 P/9$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$01QCNQ)Q5T0&> :1Y__L3I7;_#*'_9'_\ 54BB#Q!U!$T3.:Z0#S%C=H)^
M0R<?O*]K2O<TE/9:^:%Q;+'3R/:X>A#205NCL@(L4U1% "9GM8 ,DN( Q_\
M9"\35E/"YHFFCC+GAC0YP&7'L!\_D@V$6NZNIFF$.GB!G_@LO W_ ,GW_)>J
MBJ@IRWKRQQ[NV]P&?W_5!F1:LEPI(QF2IA8-Q9ET@'(!)'?N,']Q7ME93OFD
MA9/$Z6,@/8'@EI/;(],H,Z+Q-+'"S?*]K&Y RXX&2<!>T!$6..:.2,R1O:]@
M)&6G(R#@_N*#(BU3<:, $U4&"P2 ]0<M)P'=^Q/8I'<:.1[F1U,#WM8)"UL@
M)#2,AV,]L$<_-!M(O$LT<+0Z5[6-)#07'&23@#ZDD!(I8YFDQ/:\ EI+3G!'
M<(/:+RQ[7C+2".W"]("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(L0J(G-!:]I![$$<\X_I(6*.X
M4<C-T=3 YF[9N;("-V0,?7) Q\P@VD6'XJ#<&]5FX[L#<,\=_P!WJOKZB*.G
M,[Y&-A#=Q>7 - ]\^R#*BPFJA$0EZC.F6[P[<,;>^<^WS1]5#&YS7RL:YK=Y
M!< 0WW^GS09D6LZNI6/D8^>)KXP"]I> 6@]L^V5F9*Q[G-:X%S<9&>1E![6&
MJ%0Z/%*^*.3/XI&%XQ] 1_2L%ZFD@M=1+"XMD:!@CTY"W0@CNE=O\,H?]D?_
M -5>HX[H)!U:JC<SU#:9S3^_J%;Z("(B"/U'_P"[UT_S67_@*D!V"T[TT/L]
M<QPRUT#P1\MI6VW\(^B"#O\ 99KE5"6&:GB_M=\#M].9'$.<TDYW#'#2![%V
M5X=8'2FK;/)"Z&HF$SF,A+<XC:W!.[)\S&NXQVPK B"L'3,HAM[65KM]*9)"
M][">I(Z1LF2 X>7<W\//'8@@%:LFDJR2&*.2ZF1S(C&9)(G%Q<2279$@QG([
M>W!'87%$%1J-*5+XV1Q7!K6,^)_'"Z0D3=3N3)DEO4[^N/19ZK3<\]RJZMM<
M8^O(QX:UA)8&F+."78R>EW '?D.P%9T04UVF*V:LJ!+6'H&*-K26DM<=S]S=
MI>2!C:3GG."#@87IVE*^1KQ)>927Q-9PQXPX0OCW<2>I<'$?Q1]5<$05>GTY
M6PU$4C;H\,9,)2P,<=PW$EO+SCRD-^C?GA>I]/54Q:75L8,<TLD9; 1ALCRY
MS3Y^>X![<9[9XLR((..Q;*:TL,^7T438WX9ALH:!C(SD8>UKAR>Q'JM*GTO+
M%25$1K Z26G%.'['!K/N6QEP;OQG+ <\'!(R>ZM*(*D_2]8^H#W73,?6$QC,
M+B-PF,F1F0X.W# >0 .W8"7L-MFME ZGFF;.XR.D+VL+,Y^1<?7Y^JED0:%C
MHG6ZVQ4KW1O+,X,<?3;@N) #<G&,X[K?1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 7B=G4B<S&0X8
M*]H@JU)I>2GIV1BI:][9(9-\D6[&R0R':-PVYW$=S@#U66?3LLG4V3PATF Y
MTD&_C+MX'F&W(+6=SAK /I9$057]%9,2,%7&8I-Y=F#SDF/I@EV[DXR3QR7$
M\<8EW6T_8GP&]KG%I!>YI R3DD .! SV /''*DT05>MTS45-715)N4G4IHRS
M#XP]KSU&O#B"<CE@R <$ 8VCA>Y=-O='3,CJ@/AXVQL<Z,O)P\/ <"_!'E;P
M,'C@@<*RH@J]3I?K,J&&H#F/@C@C;)'NV!N-Q=R-VX >V%(:=M,UJ%4)JMU6
MZ=S7ND>S#RX,:TDG.#G:.P&/FIA$$=J'^\U5_)'](4B.RTKTT/MD[7#((_YK
(='9 1$0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exh991_02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exh991_02.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ++ X\# 2(  A$! Q$!_\0
M'  !  (# 0$!              4& P0' @$(_\0 2A   00" 00 !0($ P0%
M"@4% 0 " P0%$1(&$R$Q!Q0B05$R814C<8$D0I$6,U)B%W*"H;$E-393=)2R
MP='P"%15DM-#<X/#X?_$ !4! 0$                    !_\0 %1$! 0
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M_JD:PM'TN:3Y\ ^5 ]/X+)19^H;#;,&.QW?[+))8GQGGH,$?%H=Q#2[]?D>
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MQDL@9%D*DCSZ:R9I)_L"M]-#\("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(N>_P#X@)'Q?"#J)\;W,>&1:<TZ(_G,5%Z4HMQOQ2Z;BK8/
M(=*LEJ6GRQ6+AG;D=,;I@T]S06;+_.OL@[XB_.WP$P3KF(Z=RMCI)TQYR/\
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M#*<;"SZF0@ETAWI_D^/ U_WJMX$YS_:AIQ.7LY;(48[9S$\L[_X>^8M<8(6
MGB"UQ;O@!H [.T$]U)\+8<[A^HZD]\1V<GD'9"M9;$0ZJ71-C+?U?4"UK@?(
MV':6KDOA#5N9&.R;=5[9:]>O;%BF)G.[+ SE$2[3"X  AP</&U!=8Y7,R2=7
MWK.2L4;^!QM&S4AJ6',A[SVN=(2W>I 7#A]6QK]TJ9?*27Z^:=DKHN2=7'$/
MJ]YW9%79;P[6^/@#GRUO[[T@L/4WPI&9ZDR^6AR\E4W(&&")L6Q7M-,>K \^
M3J%@UX^_GRKSTE@XNG.F<;AX7=QE.!L1?K7<<!]3B/R3L_W4#U/U'FJW5E#
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M^%K0&&UV6\7#1V-@^=[T1]]C&SXBTY8;,M>N;#&QF6!L4C2^5H<UNBWQP)Y
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MQ.=V]AWD'ZG>?N TJZJ%Q.9FM9!]&]1DIVA$)VM+VO#F$Z]CTX'6Q^XT2II
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$&GE:]6>LUU]S60P2-L<W.XAI
M8>0)/X!"C9.EL5-+.^1LSXI^X70&P\Q;D!#W!F] GD?(_)(\DE8NOJ7\0P,4
M![Y!OT^0@<YKN/S,?(['G0;L_MK?V5%NY'-OLY%U&3)PF2M<:T%LKC%(UP[0
MT6!C7  Z#2=^=D^"0ND?2-<7,@^:U;FAM15FATD[W2,?#)(]K@\G8\O;H#_A
M.][61G1V*97$3)+K?JD+Y&VY ^02.+GM<X.V022?V^VEBZL?-C>G:L%>6Y(7
MS-B?.'OY :<XN>YC7. ) &VCVX#P/(ID.2SD<5!\DN4EE8YS65C%+&Z0-LRM
MV'&,ASC'PVV4#QIVP22 OSNE,8ZT9I!.]NWN; Z=YBC<]I8]S6[TTEKG#Q_Q
M'[E>&=)XYLE=SI;DC83$_MOLO+'NC(+'.;O1<"UOG_E&]Z4;UC:$/46&KV+N
M1K4Y*EJ1[:8>2][7P!F^ )\<G:^QWK[Z4,VQG&XZ>YDY<DV=M2BQT,;2QK7O
M_P!\\AK7$'\Z!X^2!]T%QS73./S$DC[KK $T!K3-BG?&V6,[^EW$C>N3M?U/
MY7R?I_$O@;!9 D8;#Y>,DF^<DD3HW ^?.V/=X_?:H=6]D36EBREK.5Z43K#8
M9:D4SY72:B,8V6<G#3G\>0T[[[TMZS#<K9K)RTV6WWI;U>4,E#C&6_+:W_PC
MZQHD'QK2"YX? T\5:FLP2V99I(VPE]BPZ4AC22UHY$Z Y%>3@\8;T\A)^8GC
MF:\=SR6R]OGX_P#\;/Z?W5,;?FBP\_8MYZ=[Q699DLQR1MAD)/<(=P+V[T X
M,&F[;KCLD1^.MVN[%)F)LU 16M0ME@@E,G)MC<3=EO(GAHCD/J'O\$+ZSIO&
M.O,G;+,XP/C)@^8<8Q(QH#'%F]<@ W_0%>JG2N,JT)Z;&RNKS56T7-?*YW\E
MO/BP$G8UW' 'WZ_"H,DW4$)D=:CEK">7NVWQ-E;J<5:H !C:X\>7=&OTDC1_
M!Z-T[?-RA%#:+OXC!%%\TTQN9QD<P..MC7W^V]>O:"/9TAC0)7ML7OF9).ZZ
MU\Y)W>7 ,/U;]<6@<?7@'6P"L\G2V-?X8ZQ%JM%5':L/:6LB<71D'>^327?5
M[.SO>U3,2'T:\=2Q8S=?'MGNESX62R2&?Y@\ 3ISM<""T?I<2=[]*PWK67J]
M'X7*V&6'9"KV)KU>)A+I6EO&4<&[V1R+]#[L\(+%B<;6Q55\%8O/-[I9'R/+
MGO>[VYQ/DG_Z+%'AJ38HHV \(;3[C1R]2N>Y[C_J]WC]U1+4V>K49VW;63_C
M J-EHQUHG/BDL.#G.8XAI! >0W3M , (UY(U+7\2Q]^[%5?>CJOO699WN=8V
MUY[9BXEC7'B07^ -$@ _@A>YND\9(7'_ !,?-TAD[5A[.Z'R/D<UVB-CE(X_
MML@>"5N9G#P95M7NS6(7U7F2.2O(8W-):6GR/MIQ4)E;>2_@.#?9DM1-E>S^
M)R58CW&,[3R=!H+F_P S@"1Y )]>QH]-#*W,_$;5K(C'0QRN@$K#&9F]P!AD
MV =ZY:WHD:)!03$?1V+A<U\3[C+'=?*^PVT\2REX:'!S][((8P:^W!NM:6;&
M]+XS'4HZE5DC8(YHIVM=(7:=&QC&>2=Z#8V#^RB,E9G_ -JBVS8RT+FS0-IQ
M58G.BEC.NX7G7$^2\.Y';0T$:)\UF++YC^)LLM.4;6D(FLQN9,_M<;=<N806
M!K7"(S M9O8!\N\$AT3&8#'XRW%9IL='*RN*N^9^N,.VT._)!+M'[<G?E8W]
M-XZ3(FVX3;=,+!A$SQ$Z4:(D+-\2X:!]>P#[ *I&7RF3LU7V:MC(Q0NLV1"Q
MT,T0>!P[?U-8YS?3N(+2UVSL'PMK&7\]/U3 ;4=B OF:.P]LI:("P'Z@&=O8
M\[=RWR&O1#4%U.'I'"/P^C\HZ,QN9S/+B=[\^_RM7(]+8?(94Y.U7:ZT:SJC
MY&N+2Z,N:[1((\@M!!]CSKVJ[U1';K=59"U0.0;8EHTV-,+72#MBP\3EK?+2
M]L;M@:)V? .U*]-2S309=D4ER?&M#14EML<)''B>8!< YS0=:)^Y/D@!!L'I
M?%6JD+972VVMLQWF2RSND<Z1H'$\B3].O&O1!/Y.Y'!XBEA:TT&/CX1RS/G?
MMQ.WO.S_ &^P'V  ^RYE1N9B/ 8UF'=DGAF-A;?98@D;V'AT+=,^DD.X=[88
M#X:#[T3;L"S)Y'H_(P_-2PV7F2.G8/<Y-'$<7;> YP#M^2/('W]D+!-B:4[[
M[IHQ(+T8AG:\[:]@!&M?T<5H0=+XR*9LA=/-,QS'-?/8?*Y@8=M:"XG30?\
M7[[54@R.5OM@R&6.3Q^*MN?RAAB>)8"QD;6M=H<F@O[QV/>F>='SI..:CGN7
M0,@[*2T8V1<V2#G"VW('.+&@@2]DM=K6PYW@>P@OXZ?Q[<A#>:US;4,TD[9
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M,3XZ-T$EQ]JN\/8_OL#@T%H.N!?R:T$#0UKRM6Q:RV1J9&W7LY:)D-;(6*S
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MC%7ZUN:.9]G(6+@+'O?ILCM@%S_J<1]R=DJ(Z4Z=ZLP.2N5VVL')@K60LW'
MQR_,ALKW.T#L-V-C[(C;J?$WI:STU!F6Y.O%'88]T5>:5C)GN:-EG'?ZO7C?
MW"LV R<6:P>/RD$;XX;M:.RQK]<FM>T. .OOHKE5+X8]0X['UX*M[#2R-Q$N
M$>Z>*0CLN<7-D'X?]3@1Z.AY70^B<7D\)A:F+R,M.6O2IUJT#H&N#B61!KR[
M?CRX>- >/:#>L9[$UYK4,^1J,FJ &>-T@Y1;UKD/MODW7YWX7V?.XFO6AL3Y
M&G'!,TOC>Z5H#FCV1^P_/V4#F>DI;TUZ>*=K)I,DS(1!DLD)=QK-@X.?&0YN
M]..QO7CP?(4#EL3E.GZFJ%5UZ>W4L02-U+89&Y[R\:<YQ>2>1!Y::[6RYF@"
M%T=U-B8C,ZU>J5XF/#&223L D!C8_D//@:D;O>OSZ()-ZFQ0R&0IR6HXY*,;
M)9G/< UK7CZ?/^G^H55;T7D?DF]N2N)G<=EMB6"2,?+01'C)'Y_5"26D$.!&
M_2W,ATA?ME_*[&]W;JN$PDDA>^6'D#OMZ+6N#CY#M@_8H+,W/8DNJ@9&IRM
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M6 Z;M68Q!4JN?6;#(UD3B&M#?,3BT'1UQ\$C[(-C-96U6R5+'8ZO!-;LQRS
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MD1B:-'CY;_-!UX._?KSDR^?OXK*YV5D45BCCZ\-B1CY>!:PB0OX:!V[3=^=
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M?M4FP6(9-10\0WYCNL$K6[<0[9XOV".)V/'5*74^*O7X*=6222Q,PO#1 _Z
M'.:[GX^@AS2TAVB#X]K+DL_C\=>94LF;N.,8+F0/>QG-W%G)P!#=N\>2A7"+
MO2'4^.P\E'"8_+UYV6<JY[F6B6RMD:?EW-/,_D>?!WY/GRI3K&EE>G;%X.L9
M./I>>Q0=8!R);)+MLO>;%)(\%KBX1;')N_075V=989Q?_,G:UI(YNK2-8[4@
MC<0XMT0US@"1X&]GPI6O;IY-URLUHF;7D[,S7L^GEQ#M>1H^'#U_3V$*YKT
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M<)) QSFN;*X/ V- EIW['GQZM]7YJ*]-C8HX;$]9\W*W$R-L<K8VQ./TR3,
MUW=.(<[1;Z_ 3O1/2=SIB-L)S+[E9SYYI8W5VL,DLLG/GL$D:VX:'@[W]ELY
M/IN:UE9[L%X0/<^*>+^3R,<K&N9LGE]32UQ!;H'[AP^T=B<_DLG;CE^:QU*"
M2?Y84IARF#NR'[#P[3CL[T!HL&]KYC<OD*?PVP-VQ;AGO6HZC'6IFD,9W2T<
MWCELD<OR-G\;03E3!NBQF5@GM&6UDB]\\W#B.3HVQ_2W?AH:UH V3X\D^U"S
M]#G(4Q#F;S;IAAC@KDUFM:UK'M?N1I+@\N+&\O0('@-WM:8OY2_U'C*,F0@,
M=/).BG?78YK;&JXE (#_ *2"2"-N!\'7V7KJNSEH^H,E'5R(C@:W$F&'@=-?
M)=<PDD.&P0W3AXV"!]O(6#"].Q8S!W:$?RL9ME[I#4JMKQASFAOTL;^P'LD^
M/:CLKT17R(B,\D4KH8*T<39Z[98^4(F <YA_4")W CP1K8(/J)O=59JM;.-C
MCCFM0OG+[+&1M8]L? ZX23,UXD&R'.];T-^+!D\KD9*/39Q_8K3Y.=K).^.\
M(FFO)*=<7 $@L WO2#2@Z'CKP:K6(Z\K1&YA@K,CC9(R9TP(8W0X[=QU[U_F
MV=J;Z?Q4^._B,ERVVU8NV!8>YL7;:T]J./BT;/C48]DGS]_:I=7K/-6(3,*D
M,+;$9?"+#X6B(B1C"WQ/R<?KU]09IW$'6_&WC^ILI?LMQ[K-6A;B;,Z>2W6U
MLL+/I#!+Q_3('%P>1HCUOP&\WHIYBQE>?)R25<4Z'Y)G: +6QOC<.;M_6=1\
M00&@ DD$^58L?C6U3D>;A*VY.9G-<WP-L:WC^X^G_O5-Z5ZFM7;S)[+F107I
MFN>U[R6Q#Y**732=:&^1]>?)6K#F\I<=CK\EV,U[5'#SNKL#FMYS60'.:0_U
MH^O((T#L;!#9QOPWEJV,?7L9^W:Z>QLXL4\6^&,"-S?,8=(!R>UA.P#^![TM
MS%="2XZK+C8\S9.![=AD5$11@L[Q<7$R$$NUS=Q]>_.U'7^L<I5PW\29-0D^
M8BM]JH(W<Z[H897@O/+ZM&,-<--T7#S^=S)9S/TK$U%LE2S;9*P\HH0USF.C
M<[BR-\K0X@M/^?>CZ\;01K?A9*,7\D,_.R.?'Q8N]VZS!\S7BV(];)X/#'%I
M<-[WO6UGK_#'M671G+R.Q#LL<N:(@:/Y@(+&B3>^(T-_<Z^RG;N<NR=)8K(8
MPP.LW>WX>T-)Y,)(8U[VCEL> YP\;\G[UR/K'+3U,E<BLT6,QU5D[ZTM=S99
MY.<K7QZYG@=Q\1KE]1^X]AI?]#%049Z;<I+\L(1!4#H&N="SNLD/)V]N/T!O
M^4:]@GRNB]58RUF>G[N.H9&3&3V&=L6XF\GQC8WH;'DC8WOQO:IMSK;*UY\C
M.VARJ026X&-<Z(?5"UY#M]WF>7#?'MC0?O>ALR+\CD?XA0IS9/'6IGW.#9:K
M7L[8=4G>.;.9!\M!&SH@^@0'((IGPQGBHT(Z^8@@M4.\RM+#CV!HCE;J4.8Y
MQY./@\M[W[WLJR=(X.[T_(<=%+RP-2I!!28_B9 YH=W'$@;._H_T.@ J5@<[
MEL;A\75A=+=N7*]3_$.?S/)\4DI^F69K2XZU^H;\G1T -O*]49?(=.9>5EBI
MC35I-<YKB'22N<7MYL>R0M:#Q^G1=]6QOP@W)OAO/<S&:MY/-"W#EFRPS,?4
M'=C@>-"*.0O/!H\'PWR1L[6&U\,[UK'78I>II_GKAKQ3VFU@T/K0M(;#Q:X'
M3BXEQWY]> K5U!D[D66Q^.I6*M-UF&:<V+$9D'\LQ_0&\F^3S)WOTT^/N*YC
MNJLQ>$=P.IQTVR4HGQB)SC+WY1&7-?R&F^0YO@['^J#%<^&,MNJ(3FA6$M+^
M&6A4HLC9+5#N0C:W9X$;>.7GP[TKCE,,^RV@^C.*EBB[E 3'W(]%A86N;L$M
MT?L0=@>?L:Y\3;.1JQ$T<@ZM%_#+\CVM!VYS8@6D$.&B-^#]E\RG469Q<TU%
M[(K=M]B"*.6"-K!&)&2.T6R2@.(,>AMXWS'C8T0G>G^G!B;TULV7SS3LU*Y[
M0-O,DDCB->AN0@#[ #R?:TNHND7YC*NMNN1!H=#)&):PE?"^-P=_+>7?2UVO
MJ &SL_4%C=GLI)T='=BCKQ9)UR*G_-XO9MUEL)<1&]P'@D\0XZ/C?A:,G4N:
M&;FHLA:(X+#*+Y'-B ,CF-(DT9@\?JY< P[ ]^=@).UTR(\=PXOO".I<K?+C
MBPS"=[7D<B=#7'7]]J4Z1Q4N&P%2K;F^8NAIDLS?^MF<2Y[OM[<3_;2I7^V^
M7N,JMHU&\I3'3D+6-)CMACWS,'.1C7:XM;KE]W>]:6W7ZGS=J.W8C_A]:*K0
MBG,<Q#N<CY)F;YMDX!NH@0-GWKD-;0>\1T7?DP>&AS.0(L8^I#%7;!$UIA>T
MQ/VX[(DTZ%H\!HUO[G8VLCT7-D6RR7;=.S:G=N;YBB'PZ#0T!C.7)A&B0>9.
MW'>_ $*[K3-"=U$57"Y7[KYG20PQ^&!CN)#K ;K4@)<U[M CP/*Z)B[C;M&&
M8!K9',:Z2,/#S&XM#N)(\;\A!4[O2F0A9 W&W^>IJCR^>/F\&%O$O<2X<@0!
ML:!\G1_&S!TK<K7)\C6RH9E+1=\U*:X,<@(:!Q9R^DM#0&GD?OR#E;D05;'=
M(0X^BVI7L2&%EJO99S +M0Q11AI/WV(@=^/?I1N/^'=.B&,K&I%'"(VPOBHQ
MLEXME9)J20>7G^6!L:][(<?*O:(*ME^D8<K!?@M3N[%RTZQ(UK1O3J_8+0?Z
M>=_]RU\/T3#C;E:TQU..2"=LNJE&.N'M;'*P!W'R7?S22=Z\>&C95Q1!7L?T
M_+1R%"Q%::6UFVF/8Z+9>V>5LG@\OI(<T>='8WZ]C'D^F9+DF19'D'PT<GKY
MV 1ASGZ8&'@_?T;:T ^#Z\<3Y5E1!H87'#&4G5Q(9.4TTQ=K7^\D=)K^W+7]
ME3Z_P^EAN5;HR<7SU5G&.<5 '2NY,(?,>6Y'$-+7>1L.\<3Y5_1!1;'1]JS<
M;';M/F9,Z>S-:B:V+MR.;$U@8TEWHLV-[&AHDGWOS],79KK<E)E(W9=CXS'*
M:W\EK6-E8!VP_9V)Y-GG[(] :5K1!4(>C2S$7*4M]TK[./DHOE,8!^MTCB_0
M.M_S#X_923\!RSS<GWSR$XG[?'QXA=%K>_\ FW_93J(*==Z'KWL9CZ5J?G'3
MJFNT.B:X//=AD#G-=L$ PC;?N"?2R8?HZ+&R]V*2K$YT-B-[*E1L$6Y>SY#0
M?&A"WV7$[]^ %;400?3^$EQ$\I;9;+!)%"PL,>G!T; S?+?HAH\:]_=3B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B##;JP7*SZ]N&.>!XT^.1H<UW]
M0?!7QE.LSAP@B;P<Y[=- XN.]D?N=G9_<J'ZXZC_ -EL"<E\E+>(GA@$$)T]
MW<D:SZ?R?J]??UX4)B_B W-9&6C@J#+<S7O<Q[K'"-\#60N[G+B2">^T!NCZ
M.R$%NJXNA4:UM6G6A:UYE:(XFM >007#0]D$C?OR5ZCQU*.>>>.I V:?_?2-
MC =)XU]1^_\ =5.KUI<OV\"W'8JN^MEXGR1R3W'1OB[8'<:YHC<-@D@:<0=>
MPHZG\3._TU-F'4:18QK#V(+SI9(^4@9RE B^AHWLD<O ](+[6QU*K%%%6J5X
M8H7%T;(XPUK"002 /1T3_J5D?5@DF$SX8G2C6GEH+O&]>?VY.U_4_E0O2?4]
M;J*E#+"&!\C7O'8D[\1#7!I+96CCYV- Z=^6C15@08?E*_:,78C[1<7EG$:+
MB>6]?G?G^OE>):%26W%:EK0OLQ B.9S 7L!]@.]C^RV400UGIG$30NB;CZT4
M<DS9Y1%$UO=<UV_K\?5O[[]K;=A\:ZG%4=0J&K$0Z.$PMX,(]$-UH?V6\B#4
M.-I&^+IJ0?.!O 3]L=SC^.7O7[+U%0J0U'58:L$=9W+<36 ,/+>_'KSL[_JM
ME$&M7H5*T<,=:K!%'!OM-9&&B/>]\0/7L^ORDN/IS6A9FJP26 T-$KHP7 !P
M<!OWH. /]0"ME$&G9QE"TPLLTZ\S#()2V2-K@7CT[R/?[K9?#&\QE[&N,;N3
M"1LM.B-C\'1(_N5[1!IG%8\R67FE6+[(XSN[3=RC\.\?5_=8_P""XOY..I_#
MJ?RL;N;(>RW@UWO8;K0/[J01!IVL70ML<VW2KSM<\2$2QAP+@-!WG[@>-KX<
M3CR^!YHUN4#0R(]INXV@@@-\> "T'Q^!^%NH@T_X90[MB7Y.MW++>$S^TW<K
M=:TXZ^H:^Q2[BL?>C>R[2K66/(+FS1->'$>B01YTMQ$&M8H5+-+Y.Q6AEJZ#
M>S(P.9H>AH^%H0]-XJ*_\Y\C7,K6L;%N-I$(9O7 :^GW]OV4PB#5_A]/YQUO
MY6#YIS.V9N YEO\ PEWO7[+Q4Q6/IL:RI2K0,:\R!L436@/((+AH>]$C?[K=
M1!IR8JA+6?6DI5GUWM:QT3HFEKFM] C6M#[!>;&'QM@PFQ0JRF%I9&7PM=P:
M1HANQX&O&@MY$&O=I5;T'9NUH;$.P[A*P/;L>CHKZ:=8EQ,$1+BUQVT>2T[:
M?[$ C\+.B#6NT*=YK&W:L%AK"2T2QAX;L:.M_L2/[K[/2JV&3,GKPR-F:&2!
M[ 0]H^QW['D^UL(@P,IUF5XX&01"",M+(PP<6\2"W0]#1 (_&EYDH5)+K+CZ
MT+K;&EC9BP<VM/L!WL#]ELH@U)<91FK35Y:E>2"9Q=)&Z,%KR?))'HG^J]_(
MU>#F?+0\'1B)S> T6#>FG]AL^/W*V$01S<'BFU(ZK<;2%6-_<9"(&AC7>^0;
MK0/[K<AKPPOE?#$QCI7<Y"UH!>[0&S^3H ;_   LJ("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@T<QBZ^6KPPV
MVN<R&Q%99IVM/C>'M/\ JT*!J= X*BZ5^/KS4Y)+$MGG6L/B<UTO$2 %I&FG
M@WZ?0(!&B 1)]9BX>E<J<98DK7&UI'121LYN#@TD #\_A?>F[GS&(JPS.E-N
M*K"9^XUP/)S ?)(\GP=^_P!T'ROTYCZTF)=5A[(Q<;X:K&N/%C7  C]_ 'DK
M2I]&4*>+..BL7S2 ;VXS9<.R6NY-+"-$$']US?IZ#J^IC>CLI-+?>V<1"Q4?
M>GGDGD^7F<72B0#M NX@M&V[U^ L_P#MWU=)T[-:&-='9#OH_P#)\WZNRY[H
MW GP X ;'+>]:WY0=.P?3U/#3224W6 Z4O?-SF<X2R.+=R.!\%WT@;^P\!3*
MY+=ZRZLKY'("'%.L11TC8AACI2D!W;C/U./'9VY_AO+EQT"""IJIU/FW=!RY
M26F?F6VV0A_R\F^P96-=,8_!/%I<=#P>.QX*#H"+BV+SO5+)0VNZ>5\]MS!/
M9@F<QK'Y*1F^V7#0$6B![#=>=*2;UCU6<AEJPQ)U5>YA<:LA[3>^QC9?'B0&
M(NDT#OZ=!!U=%0.G,AE[?6%8V[L\N,EQTA8?DGUXY9&S$!VG>0>&C^"/(\$*
MM6<AU97RMYT-VT^2I_%I6,EK/,;FL,#H&EH(#MCEQ/X<[2#LB+G?2G56?RG5
M\U"_C#5I-#R>4,C> '$L>'_I=RY'Q[__ &NW"ON9B'-6Y<8[+V\G%F+'*JZ2
M4P/J"-Q (=_+:.0;Q(T=Z]C:#KR+B]7KOJBT['Q3"''_ ##I=S28V9Y);"'E
MG;V#X<>.P3[T?(\[]7J[K.:-CIL0RM=<QX?1?3F<(F_*]QLQD:3R'=^C@ 2=
MZ'D'8=91<0EZBZNR.*M2-;<KVHZ<[FRQ5)&\BV:OKBW>G?2Z3ZN(.FGP-'<C
ME>L.K&9^:CCZP= Z9L4<TN/D 9_B:\?(Z=IP,<KW[V/ WIH]AUY%0>F\YFK?
M7>2P5TQ.K8QKI9;#(]=YL@88![\$:FY?]5OY4!'GNK,7 [LPRWF3V,B6B:O(
M]]=L=]K&NWO;FB*1S@WQL1@!!UU%QJ_UEUI3M1&/'?-T.X][;#:DC#+!"XND
M?Q\D.>PM#0?9!(\'0LF8N]1.Z+Z?G<Q\68MRQF<01O'9YQO=KB#_ )3Q!#MC
M80=!1<\AR&79T=T7,3/9R$\D3;A>R1K@?EY"[FUNCX> #O8W]MZ6/IG,=1YK
MHKJ"6XV6'*0QN;6?'3?'R=V0[Z [1=]6QY:"#X()"#HZ+E^)ZCZD^<Q-9\+Y
MHW?*1N#ZCPZQ&^,&:8R;XL+';'$C_+^7-UL=0=0]4T>I<KC\;C?FXJ]23(0/
M,)XR,[8:V$$'R_N\G>//$:]G:#I"+D%_J'JT7(+%-D]NM6FL-B,=-\3;Q^5+
MV-<TDD?S-LWX!/[@J0_C^?R_PLZIN&*:"]%!*VG+!#)#*\]H'8:?.PXD;'X_
M(*#IZ+CV3ZSZIQ_)D;:UUDMW^&UIQ4?7Y3RQM,;N#W$\6/VUQWY!_(*F.MNH
M\_B<]\CB'13R18T6VUW4WRNMR]PM$8<UP#.6O9!U[^Q0=)1<>@ZFZGQS<=!'
M7LV!+D9VR]^N]Y,;LB^(:DWX#8RT@:  XG>M!9K/4_4<F/HV.U(Z[W><U9M&
M>,57_*V7&)SM\9=/9&/ZD'[MT'6T7'LAU?U7CPV&P:[>;(YOF3CY'\2ZL^4Q
MB-KMD![-%W^4'S^5.]0=2YNOT)@\ECHB_(7:\<DO"JZ5H<8#(1H';07 #T[W
MK6SL!T1%S7!=1=2W,O2DM0,91L9!M-\'RK@8V&B)S)SWZ$FV>1K[>UFZ]HY>
MEC<C>K9;)2V97AN/J4VN:6SN='VP2':+-L/(.&N+G>O)(=$1<ZZ$QF1R5"I>
MRF3S$&2AG?\ /UI)7AAF$G)S6M)X]OT&Z&N!^Y.QBS66ZCCZMR5+&<H:YG/&
M:2N^9O%M-L@X@NXC;]CQ^_W\H.E(N;=39+.V,+TE?K26*CK43WWHH(7'BYU1
M[FM/W;_,T!^Y'X4))U9U;B,97@?5?;:(*;W6W5)'NCYP/+FN )+CS8T$^_KT
M?)"#LB+GG6G4>?QO2>,NT*9&2G@,DT(K/F:QXA+^!T06_4->6DGUH'R*MFNO
M^J:M/,7*;*T@JS2PFL:,G^'8V 2"5TG+1T\AO'6SR_*#MB+F6,S_ %79S\%(
MLBEHM?8<;8H20BRUC(G!K6N=]'U/>SD=@\?6PH5_6O57SV'K3&&E%>X]^S)C
M)C\K*8)GO@X<@7EIC:>0];\^"@[.BY-7ZAZMNUGSWZ9JB.WC(Q5CKRL?_,DB
M[KB0[?$ N^D^MD.WHA:V.ZEZJRLE1U@6*D,62J&1S:+XRZ&5C^3'M).@UP:#
MY.B[1.P@[$BY]\/^I,[GG9,9G'NIB&,$-,+XW12DN#H]GP[0:T[!^^_1"JG3
M'5'5L.)PM6RY]F)]2J;E^7'S=R@71NY<PYVY7$M;MWC7(DC6D';$7+<'U7U+
M9ZFPM7)U/EZ-F$.MN%-X,,Q$G"/9/TAX:'_4"6^&D[<%\Z]ZNZEPLN<?CZC'
M1TF.,,;ZKW"2(5S(ZP9 >(#7@MXGWK7MP0=31<>?UCU,V[3J26:T<%B5P%\X
MJ;3M0.D<P1<^1+7 -Y;UYU[!6R[J[K)S(G.Q#:]MS(?\$ZG,\/:^'G)+S:?I
M#'[;PT3XU[<U!UA%P^;J+K#)8FT]K+D%N.A;<R:&I(SDYCZO'BTG3O#Y0'%H
M=])  T[=PZ>ZFSMSKF;%V:/'',Y@2F![=L#&EDH?^D\R3X\?CVT[#H"+E$_6
MG5'S^;A_A;H657O8T_)R2&,=]K(W;V&O#HW%Y._&MZ(!"V<+U3U#;;BCD(#3
M$C1S(Q\TOS$GS,D;F:&C'J-C7[(U]>]:!"#IR+GGPOR&=DCH4\V^6:-^*AM"
M6:)S9&RESFN8YQ)Y'0!\^?*Z&@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B 1M:^0L,I8^S:>-L@B=(X<@WPT$^W$ >O9('Y6=[FL:7.(#1[)7B4130/;
M*&OB<TAP<-@@CSO]D'.F_%"*2G(^/#VWV8Y)6O@[C&@-C@;.YW)V@?I>W7Y.
M];'E8I/BOCNQ-+#C;LK(X_!:/!D#&O<PDC0\/ !WY(/H:)L.3Z$Z=R=)E-E6
M.K79+WW1U6,:U[BSAMP+2-\= ._4- @@^5(MZ2P#7N?_  BB9'0MKN>Z%I<Z
M-H #22-D::WW^!^$%-S_ ,1Y:F*S3*>-XYK'0V))8I'AT;!$(SRV".8/=9X&
MC^K\#=AQ'6$&1ZMLX!M26-\;)GLFY-<QXB>QC_(\ [>WQLD>>0:?!D\ATK@L
MB7&_B:-DN>Z1QEA:[;G!H<3L>R&,!_ZH_"SU<+B:V4EOUJ56/(2!PDG9&T2.
M#B"=D#?DM!_L@Y_%\2I:\X==I-=3=!RC?'L2.E-IT#6\?.A].]^3X/Y 6[%\
M289PYU?#7'1,=6CE+W-8YCYIY(&CB[1/\R/W^#O]E;I>F,)+%VI,52?'P=%Q
M="TC@YW)S?7HN^K^OE>H>G,-7A$4.,IQ1 1#@R%H $3B^/P!_E<21^"=H/G2
M^7CSV%@R#('P<R^-T;R"6N8]S'#8]CDTZ/X4MQ'X6E0Q./Q\KI:5.""1[>#G
M1L#26\G/UX^W)[S_ %<3]UO'P@^<1^$XC\+ZB##)4KRSQ3R01/FAWVY'-!<S
M8T='[;'M9>+?PO)E8-[>T:]^5['E!\XM_ 3B/POJ(-:K0IU))Y*M6""2P_N3
M.CC#3(_6N3B/9U]RMCB/POJ^!S2[B".6MZ0.#?P$T%]7P.:20""1['X0.+?P
M@: / TOI( V40?.#?P$XC\+Z3KVOC7!Q(!!(\']D#BW\!?=#6OLB(-:>A3L6
M*]BQ5@EGK$NAD?&'.B)&B6D^1L>/"]FK ;7S)AC^9X=ON\1RX[WQW[UOSI9D
M0?.#?PG$?A?4!WZ0:N0QM')1-BR-.M;C:X/:R>)L@#AZ(!'O]ULAK0- #2^K
MXYP:TEQ  ^Y0.(7T@'VB^.<&ZY$#9UY0?0 /2^$ HUP=O1!UX/[(YS6@%Q !
M.O*!Q'X3B/POJ$@>T'SB/P%JOQE%\%F!].NZ&RXNGC,8+920 2X>G'0'O\+:
M:]KB0""1['X7U!\XC\+%+4KS2PRS01220.+XGN:"8W$%I+3]CHD>/L2%E:X.
MWQ(.O'A?4'SB/PG%OX7GNQ[US;O^J]H/G%OX3@W\!?40?.#?PL=FM!:@E@LP
MQS02M+)(Y&AS7M(T00?!!'V65?'.#&ESB !]R@PNI5GR02.KQ.D@WVG%@)CV
M-'B?MX\>%FXC\+SW8]'3V^!L^?2]@@C8.P@^<1^ @: ? 1SFL!+B !]ROH._
M2#YQ'X3B/POJ(/F@OJ^<VEW$$<OPOJ B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B(*S\0X;,_3CFT<4<M9$T;HZSGAL>P?U2 N;S8WV6[\Z _<1E3%VF?#
M3)8&O2NB=N-EAB-CMM[KWL?]+0UY#0"= 'P 0-G2O*T<[)8APE^6D]K++*\C
MHG.9S <&D@D;&_/V0<UJXK)=,="]577SST<B; LP322=PO#&1<&'1/TN<TLU
M^"D4'74]2G9;+<;8M01V8V-E8&59WS.?)',UPV6-B<Q@ !\M=X!(*]X7X@91
MT6'BG;2LR2,H,E !;+:-C0?+&!X C.^0T1]+O+=:4CU/U)E,-UC=%5T4N/@J
MXUSZ\K3Y,]J:)Q:1Z.N!\['T^O.T'OHT]6AX9EX;#'P8ED!?9D8Z.:VU[^3Q
MQ<3HCCY('A5K%8OK 9*2]9K9:*.S%49?X3P"Q(YD<_/MN#M!HE>PZV/'@#7A
M98/BQ>;1RM^Q2JNHXU]:2=T(<7"&9TK/ Y;VUT;/+@TZ<=L&O,OANO\ *6.L
MZ73V0QD<5ES8VV "&$$U^ZZ1@<_D6!VV:XGT3R\:0>LO0ZPMX;#,-JRR_%BK
M1MOJ3-9SM\8^R#Z!\A_H<??V*BLKBNM\K2R-6P^V'V8+3)-6(V0/8Z B!C /
MJ:\2:Y'P-<MD@MU*=5]=9'%]42XN**@R$31P-;*YW?E:^%[S*P#QQ!:&_?SO
M]E%U?B1EZT38'XQMJ:+$-S!$;7ESX#781YW^HS%P_P"JTG6T$YGZ/4WRW33<
M'):BCDC93OMDF'.NPF-QF]GD]H8]G@G_ 'G]U7LCANL\CC)(;YR$A8:\MAC;
M,;1+.RVQ[G0<2.+.T'^'%OD,\;!*,^*.8M4;EFG4Q_;I4KMY[W_6+#:X@.F<
M)'!F^\YOZG:+/[*Q_$WKFUTCC:EJK!6F=)%+.Z.7>W-8&DM!V ">7O9/X:[S
MH'2S>L1U1E#F7EN/ G[7AAB>3(#"6$.+AIFP06M\_D^5"X[']<SY;",NVLE#
M1YQG*/\ F(MNE$4W,Q<?(A+NT->"/&@""5<NN>H7X*'',8^O!\],Z$V;)U%#
MJ)\GGR/)X<1Y]G?G6CS'#_$O,TNCZ5Z<U;$SGQ,EDL.VYW^"K2G306GRZ5V^
M/(C[,=OP%MZ@Z=RF3ZSCL&"8XZ/)TYP6RM:TL9#)R<1O9T_M^_[*.S<O5EKK
M/.XW 7Y75*<3;;7!W$MDD#&_+ N''PULLC=[ <]N_"W;_7^1CAMOJC$BP+K:
MD5&9SQ/&/G(Z_<D _P K@\O'@:!;^K9U%]4?$;,PV>H\30K10W:%.RYDYC;R
M:Z*OW.\(R\DM<3Q:"T@;:2YVRU!EO1]=P5,I\G'DYHYZER''QF>$S5WN[1A=
M*2X D$2Z(+B 1O95@KX[J/\ V*RX?<N#/23V9:PDE!# V=YA8-> US P'9WI
MQ\CT()G7N2JLM,[F/<18E NSEPKN$=6O*&-T?!D,KN/DZ )TY!\2LNR$WK-"
MG!4?+/ ()&R"6%T=3YC;R-[^[2 T'[[^R#U6I]=R&O)9EMMGG,,[6,GC[-;G
M,]T\4N_+N,;FL:6[_3XUY*T,/TYU52^3K1-OP0AT44\PLL+^'SDCGZ=LG7:<
M#_?\J2Z?Z\Z@S]EE*A6QK+0ANO<^1KBU[H71-8 &R$#9E /U'6CY^RE<!UO<
MS'0F;ZFCJ110UH99*L3VN!<8X07\_/KN![?&O#4%1EN=6TL]BL?=NY1T_P S
M7$<4;V$/KB]()'2^-OW (CMIVT;Y:V=SG4&)ZKL=5YF7&ON5\?)#-) ^O,QG
M.85X1$#YV?Y@D]^/SX*\8SK_ #=W+T,:R#$S/L2,Y6JYDDBXF"24L;Y\R-[8
M!\_YV^ M.S\4<M%AGWHJ-"S-\M7MMJQ=PO!E>6FH[6R)AHG>O\KOI&MH-?*X
M;K?*,S$-TY&6"6%DD;6V(XFEXDB=P: X[/$2>?H_?EL$3L5?JNBZ.X?XG;#L
ME<YU1/&2VL6RBOQ!<!H$L)V=_P"FAFZ>ZVR63ZKIX4Q49A-6;D#;KM?VWU3$
MW3F[/AW>);Y_RCUM8,AU;E\9U/F:4EFB:_SU:M ^>(M939) YYDD(=MS2YO'
MR1]3AY'I!H0XKK"_T_/3S)RCKT^.[3716HFP _*-!;)YY&0S\]D?D?5QV%AB
MQ?65<6A5CR,-5[=Q-BGA$_>%2LV-SW.)!8)&S!VR=^/!"G\UU1E9_AC4S])T
M&,N26*[9#+'W8Q&ZRV-SARX_26GEL_Y3]CIP@Z_7V7P^+FGN0,R,;H\I8BXM
M(D8*]T1 ..]%H;(T^AH,.R=^ RR8[KP1RR_.7?FY9+4;Q%+&8VQ]D&-S&N(
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M@@Z(*VOB+UG4Z/9BQ)5BG-F8]X.<&]JL-=V0>/.N3?I^^_V4I6Z&Z>JQ<*]
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M0MA:7E[F2/82-_2-1/WRT6Z^H!2_2/2\'3[<J_N=^UD[3[=F4L#.3G>- #P
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MT-*3O4JM^L^M?K06:[]<HIHP]KO._(/CV%[K5X:L#(*L,<,$8TR.-H:UH_
M\!!D1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1!'&/+$G5ND!OP#4>?\ _8G:RW_Y
MRC_[H_\ _E4BB#Q!W!$T3.:Z0#ZBQO$$_L-G7^I7M:6;FDKX6_-"XMECKR/:
MX?8AI(*W1Z0$6*:Q% "9GM8 -DN( U_]D+Q-<KPN:)IHXRYX8T.<!MQ] ?O^
MR#81:[KU9IA#IX@9_P#=;>!S_P"K^?[+U8M05RWORQQ\O7-P&_\ 7^J#,BU9
M,A4C&Y+,+!R+-ND \@$D>_8T?]"O;+E=\TD+)XG2QD![ \$M)];'VV@SHO$T
ML<+.<KVL;L#;CH;)T%[0$18XYHY(S)&]KV D;:=C8.C_ *%!D1:IR-, $VH-
M%@D![@\M)T'>_1/HI'D:<CW,CLP/>U@D+6R D-(V':WZT1Y_=!M(O$LT<+0Z
M5[6-)#07'6R3H#^I) 7R.:.1A=&]KV@EI+3O1'L(,B+Q!-'/$V2%[7QN&VN:
M=@C]BO: B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(
M@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(
M@(B("(B B(@(B("(B B(@(B("+$+$3F@M>T@^B"//G7_ (D+%'D*<C.4=F!S
M.7#DV0$<M@:_KL@:_<(-I%A^:@Y!O=9R/+0Y#?CW_I]U]?8BCKF=\C&PAO(O
M+@&@?G?X0946$VH1$)>XSMEO,.Y#7'WO?X_='68FO+'2-#PWF6EPV&_G^B#,
MBUG7JK'R,?/$U\8!>TO +0?6_P ;69DK'N<UK@7-UL;\C:#VL-H6'1ZJOBCD
MW^J1A>-?T!'_ (K!FII(,78EA<6R- T1]O(6Z$$=VLM_^<H_^Z/_ /Y5ZCCR
M@D'=M4W,^X;6<T_Z]PK?1 1$01_4?_H]E/\ V67_ . J0'H+3S30_#WF.&VN
M@>"/VXE;;?TC^B"#S^%FR5H2PS5XO\.^!W.N9'$.<TD[Y#7AI _!=M>'8!TI
MMMGDA=#8F$SF,A+=ZC:W1/+9^IC7>->M*P(@K!Z9E$./:RZ[G5,DA>]A/<D=
M(V39 </IY-_3Y\>B" 5JR=)7)(8HY,J9',B,9DDB<7%Q))=L2#6]CU^/!'H7
M%$%1L=*67QLCBR#6L9\S^N%TA(F[GLF39+>Y[^^OLL]KIN>?)6[;;QC[\C'A
MK6$E@:8MZ)=K9[7L >_(=H*SH@IKNF+LURP);A[!BC:TEI+7'D_DWB7D@:XD
M[\[T0=#2].Z4OR->),S*2^)K/#'C3A"^/EXD^Y<'$?\ */ZJX(@J]?IR[#8B
MD;E'AC)A*6!CCR'(DM\O.OI(;_1O[Z7J?IZU,6EUV,&.:62,M@(TV1Y<YI^O
MS[ /KQOUOQ9D00<>"X5L2PS[?2B;&_3--E#0-;&]C3VM</)]$?=:5?I>6*I8
MB-P.DEKBN'\'!K/Y+8RX-YZWM@._!T2-GVK2B"I/Z7N/L![LIN/O"8QF%Q'(
M3&38W(='CI@/D #UZ E,1BIZ.)FJ2313R2.>[FZ(AI+O^)I<2?/OSYVIE$&E
MAZDE*BV&:1LL@+G.D:SB'.<XN)ULZ\G\K=1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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09.UPV"/_ )K='I 1$0?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
